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CHAPTER 1 
INTRODUCTION 
Urethritis in the male accompanied by discharge and dysuria has long been 
related to promiscuity. After Neisser 1s discovery of the gonococcus and the 
introduction of the Gram stain in 1880 differentiation between gonococcal and 
non-gonococcal urethritis (NGU) became possible. At the same time ophtalmia 
neonatorum -then a common affection- could be divided into a gonococcal and a 
non-gonococcal form. Clues for an aetiologic agent of these sexually transmit-
ted non-gonococcal infections were found three decades later. 
In 1907 Halberstaedter and Von Prowazek observed typical inclusions in con-
junctival smears from monkeys infected with trachomatous material ( 16). The 
eye disease trachoma, which finally leads to cicatrisation of the cornea, had 
long been known. Similar structures were observed in conjunctival smears from 
neonates with non-gonococcal ophtalmia neonatorum. A few years later inclu-
sions were observed in cervical and urethral cells from the parents of a child 
with ophtalmia neonatorum. Moreover, the typical inclusions were seen in 
urethral smears from men suffering from non-gonococcal urethritis (NGU). 
Experimental infections of simian conjunctivae with material obtained from 
neonates with ophtalmia, with cervical smears from their mothers and with 
discharge from patients with NGU revealed the relationship between ocular and 
genital infections on the one hand, and on the other hand that they ~ere 
sexually transmissible. Moreover, the aetiological agent was identified. 
Further research into this micro-organism, Chlamydia trachomatis, was serious-
ly impeded by the lack of a suitable culture technique. It was not until 1957 
that T 1 ang succeeded in culturing Chlamydia on the yolk-sacs of incubated 
hen 1 s eggs. This lead to renewed epidemiological research, the results of 
which were not essentially different from those obtained at the begin of the 
century. The introduction of Chlamydia cultures on continuous cell lines by 
Gordon and Quan (13) was a great advance in epidemiological and biological 
Chlamydia-research. 
The genus Chlamydia is taxonomically assigned to a separate family, the 
Chlamydiaceae, order Chlamydiales. The genus includes two species: Chlamydia 
psi ttaci and Chlamydia trachomatis. So far, 15 serovars of C. trachoma tis 
have been identified: A, B, Ba, C, D through K, Ll, L2 and L3. Since Chlamydia 
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are micro-organisms growing only intracellularly, they were initially 
classified among the viruses. However, Chlamydia contain ribosomes, multiply 
by binary fission and are sensitive to antibiotics such as tetracycline, 
erythromycin and rifampicin. They are therefore bacteria, which require a 
eukaryotic cell for growth. Moulder established that they were above all 
"energy parasites", dependent on the host cell for ATP, among other things 
(29). The organism can exist in two forms. One measures 0.3 p,m and is 
metabolically inactive but infectious. This form, known as Elementary Body 
(EB), invades the eukaryote by an as yet unexplained mechanism described as 
"parasite-induced phagocytosis" (5). The phagosome that contains the EB does 
not fuse with the host lysosomes (10, 12). Within the phagosome the EB 
transforms into the larger (lp,m), vegetative but non-infectious form known as 
the Reticulate Body (RB). After a large number of fissions the phagosome, 
containing numerous EBs and RBs, is microscopically visible as an inclusion 
vacuole or inclusion. After the transformation of the RB into the EB rupture 
of the host cell occurs and the infectious particles are released. In this way 
the infection becomes manifest. The entire cycle takes about 48 hours. 
It is now certain that Chlamydia trachomatis is the aetiologic agent of 
trachoma, some of the sexually transmitted non-gonococcal oculogenital infec-
tions, and Nicholes-Favre's lymphogranuloma venereum. The three groups of 
diseases are associated with different serovars of Chlamydia: A, B, Ba and C 
are found in trachoma, D through K in the oculogenital infections, and Ll 
through L3 in lymphogranuloma venereum. Many epidemiological studies have 
reported the presence of Chlamydia trachomatis in oculogenital infections and 
related diseases: non-gonococcal urethritis (8, 31, 35, 39, 41), acute 
epidydimitis (3, B), and Reiter's disease (19, 25) in males, and cervicitis 
(8, 31, 35, 41, 42), urethral syndrome (4, 38), bartholinitis (9), peri-
hepatitis (8, 30, 32, 45) and salpingitis or pelvic inflammatory disease (PID) 
in females (8, 11, 18, 21-24, 40), proctitis (8, 31, 33), paratrachoma and 
neonatal conjunctivitis or pneumonitis (2, B, 31, 35, 37, 41). The infectious-
ness of Chlamydia was demonstrated in contact-tracing studies (42, 43) and in 
a prospective study of Chlamydia-positive pregnant women with regard to 
neonatal infections in their children (1, 17, 36). Serological studies pointed 
out the role of Chlamydia in the pathogenesis of tubal infertility (6, B, 27). 
Chlamydia and gonococcal infections are often found to be entirely analogous 
as to clinical symptoms and sequelae, and in most cases this is obvious. 
However, apart from numerous publications indicating a high prevalence of 
Chlamydia in various oculogenital infections there are reports raising doubts 
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about the pathogenetic significance of the presence of Chlamydia in the 
urogenital tract. For example: strikingly high rates- (25%) of asymptomatic 
chlamydia! infections in males (39). The incubation period of a chlamydia! 
infection is uncertain but for convenience held to be ten days or more. 
However, the organism has been found in NGU patients without known recent 
sexual contacts. Several contact-tracing studies have revealed large 
percentages of asymptomatic patients (42, 43). A study by McCormack showed 
that Chlamydia may remain in the cervix for months or perhaps even years 
without giving rise to symptoms (24). Although Swedish and French studies 
strongly indicate the relationship between salpingitis and Chlamydia (18, 22-
24), the organism is rarely found in the salpinx in the USA (11, 40). Yet 
various screening studies in Europe and in the USA reveal similar chlamydia-
prevalences in diverse populations. The differences found in salpingitis are 
explained by differences in sampling and culturing techniques, but proof for 
this assumption has so far been lacking. As regards the pathogenicity of 
Chlamydia it is the large percentage of subclinical infections that raise more 
questions than are answered, particularly since on the other hand serious 
conditions such as salpingitis and subsequent tubal infertility are being 
related to Chlamydia. Richmond (34) suggested that so-called latent chlamydia! 
infections may be activated by several external stimuli, e.g. the presence of 
other micro-organisms. The prevalence of Chlamydia is higher in longstanding 
cases of NGU than in recent cases. Latent chlamydia! infections -i.e. presence 
without growth- have already been demonstrated and studied in tissue cultures 
(28). Darougar (7) demonstrated in an animal model that combined chlamydia! 
and streptococcal infections took a more severe course than infections caused 
by the separate micro-organisms. Unfortunately, no analogous experiments with 
regard to genital infections have so far been performed. 
The mechanism by which the organism damages the host is likewise very un-
certain. Mgrdh (24) already noted that higher antichlamydial antibody titres 
reduced the chance of actually isolating the organism. Moreover, higher anti-
body titres were associated with more serious clinical symptoms, e.g. in the 
case of salpingitis (44). Although only one case report on Reiter's disease 
mentions isolation of Chlamydia from the synovial fluid, the immunological 
respons of the host to a (recurrent) chlamydia! infection seems a more likely 
cause of the synovial damage (25). Grayston and Wang (14, 15) also hold that 
chronic trachoma characterized by pannus formation and cicatrisation is a 
result of the immunological response to chlamydia! reinfection. It seems as if 
Chlamydia themselves can cause mild but clinically evident infections in some 
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cases. For serious damage to the host or complicating infections, however, 
an additional factor is believed to be required. At present one can only 
speculate whether an additional microbial infection or a unique immunological 
response of the host to chlamydial antigen is involved in the pathogenesis of 
the more serious forms of infection. 
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CHAPTER 2 
PROBLEM DEfiNITION 
This thesis takes a closer look at three aspects of human chlamydial infec-
tions. With regard to diagnosis the influence of logistics on the sensitivity 
of the culture method is discussed, along with optimalization of the culture 
itself and an evaluation of new diagnostic methods. Next, epidemiological data 
are discussed with regard to the prevalence and role of Chlamydia, on the one 
hand in asymptomatic persons from low-risk groups and on the other hand in 
women with postinflammatory tubal infertility. Finally the therapeutic 
problems are considered with reference to measurements of the in-vitro 
sensitivity of various chlamydial strains to tetracycline and some recently 
developed chemotherapeutic agents. 
The significance of Chlamydia for some of the sexually transmitted non-
gonococcal oculogeni tal infections was not generally recognised until rela-
tively recently. One of the reasons for this was undou~tedly the lack of a 
culture method to isolate the organism for study of its biological charac-
teristics. Even after the introduction of a technique to culture Chlamydia on 
cell lines, large scale epidemiological research was impeded by lack of 
adequately equipped laboratories where the complicated method might be 
employed. The manner of collecting patient material for culture, transport 
from outpatient clinic to laboratory, and the culture method employed are 
critical parameters which determine the ultimate result. A disadvantage of the 
culture method is the relatively long time required (6 days). Rapid diagnosis 
and if necessary treatment, especially of asymptomatic persons, is of great 
epidemiological importance. Chlamydial antigen-detecting methods have recently 
been developed which can present results within a few hours. They are based on 
the immunofluorescence (IF) technique and on the enzyme immunoassay (EIA). 
Both techniques employ monoclonal antibodies against genus-specific epitopes 
of the Major Outer Membrane Protein (IF technique) or of the lipopoly-
saccharide (EIA). The chlamydiae in patient material need no longer be alive 
for analysis, and transport to the laboratory therefore no longer influences 
the sensitivity of detection. 
Regarding diagnosis, chapters 3 through 5 attempt to answer the following 
questions. 
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1) How does transportation of the patient material affect the sensitivity of 
the culture, 
2) How can the traditional culture method using vials, subpassage and Giemsa 
stain be optimalized, and 
3) What is the value of chlamydial antigen-detecting techniques. 
Chapters 6 and 7 present studies of the prevalence of chlamydial infections in 
populations who in symptomatological terms are at the extremes of the patho-
genetic spectrum. The experience obtained with the rapid, sensitive microtitre 
culture method was used to investigate the presence of Chlamydia in semen 
samples destined for artificial insemination by donor (AI). Screening of the 
donors by AI institutes is usually based exclusively on the donor's history 
and assessment of the fertilising potency of the semen. The donors are select-
ed from so-called low-risk groups and are asked before they give semen whether 
they have symptoms of a urogenital infection, e.g. dysuria or discharge. The 
semen samples were tested not only for Chlamydia but also for other micro-
organisms associated with sexually transmitted diseases (STD). 
In addition to this study of the prevalence of chlamydial infections in a-
symptomatic males who on the basis of anamnestic data are not considered to be 
at risk, the role of Chlamydia was studied in relation to the most serious 
complication that may be caused by an ascent of the infection from the lower 
genital tract in females: postinflammatory tubal infertility. For this purpose 
infertile women were screened for serological evidence of a history of 
chlamydial infection. In most of these women tubal pathology could be 
established, suggesting an inflammatory process in the past. Especially· 
Swedish investigators are convinced of a strong association between 
salpingitis and Chlamydia. A prospective study by Westrom has shown that the 
risk of tubal infertility following salpingitis is 11%. This risk increases to 
more than 60% in women with a history of three or more episodes of salpingitis 
(2). To investigate the role of Chlamydia in the pathogenesis of tubal 
infertility, a prospective study would be required of the course of events 
following cervical contamination of women with Chlamydia. Since this is 
neither ethical nor feasible, a transverse study of women with tubal in-
fertility was started. They were serologically tested for the presence of 
antichlamydial antibodies with the aid of the micro-immunofluorescence test 
developed by Wang (1). Although the presence of antichlamydial antibodies is 
not conclusive of a chlamydial aetiology of tubal lesions, such a finding can 
support the postulate of the role of Chlamydia in tubal infertility. Because 
gonococci and Mycoplasma hominis may play a role in salpingitis beside 
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Chlamydia, antibodies against these bacteria were likewise searched for. 
So far, tetracycline and erythromycin have proved effective against chlamydial 
infections. As with gonococci, however, the possible development of resistant 
strains will have to be taken into account. It is therefore necessary to 
develop methods by which the Minimal Inhibitory and Bactericidal Concentration 
(MIC and MBC) of isolated strains for these and newer antibiotics can be 
determined simply and effectively. To answer the question whether the 
resistance problem reported for gonococci also arises with regard to 
Chlamydia, the MIC and MBC values of 22 chlamydial strains for tetracycline 
and some recently developed chemotherapeutics such as temocillin and the 
4-fluoroquinolones were determined. A rapid microtitre method was used for 
12 strains. 
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CHAPTER 3 
SURVIVAL OF CHLAMYDIA TRACHOMATIS IN DIFFERENT TRANSPORT MEDIA AND AT 
DIFFERENT TEMPERATURES: DIAGNOSTIC IMPLICATIONS* 
K.H. Tjiam, B. Y .M. van Heijst, J.C. de Roo, A. de Beer, Th. van Joost, 
M.F. Michel and E. Stolz 
We compared the survival of a laboratory strain of Chlamydia trachomatis sero-
var L-2 in different media and at different temperatures (room temperature, 
4·c, and -7o•c). At these temperatures the best storage medium was 2SP 
(0.2 mol/1 sucrose in 0.02 mol/1 phosphate buffer supplemented with 10% fetal 
calf serum). We used material obtained from patients to study the sensitivity 
of the culture method as a function of sample storage time and temperature. 
Compared with results on direct inoculation, material stored in 2SP for 
48 hours gave 11% fewer positive cultures at 4•c and 14% fewer at room 
temperature. Of samples which ga;~ negative results on direct inoculation, 4% 
were positive after storage at 4•c for 48 hours and 2% after storage at -7o·c 
for a week. As expected, the number of inclusion forming units in the original 
material proved to be important for the percentage of positive cultures among 
the stored samples. 
INTRODUCTION 
Culture of the organism from patient material on a suitable cell line is still 
the most important method of diagnosing chlamydia! infection. Many studies 
have aimed at improvement of the culture method. The sampling of material (1, 
2) and the cell line (3, 4) have all been subject to investigation. Few data 
are available, however, on the survival of c. trachomatis in the most widely 
used transport medium, 2SP (0.2 mol/1 sucrose in 0.02 mol/1 phosphate buffer), 
and the diagnostic implications of survival rates. For such studies it is 
important to use patient material that, unlike clean laboratory strains, is 
rich in many substances and cells (such as leucocytes, antichlamydial anti-
*Br J Vener Dis 1984;60:92-4. 
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bodies, bacteria, and sperm constituents) which can influence the growth of 
chlamydiae on the monolayer, Reeve found a 17% decrease in positive cultures 
after storage of the material at -70"C for one week (5), whereas Ngeow 
observed no loss after freezing the material in liquid nitrogen ( 6). We 
studied a) the survival of a laboratory strain of c. trachomatis, serovar L-2, 
in three different media and b) how storage of patient material under 
different conditions influenced the sensitivity of the culture method. 
MATERIALS AND METHODS 
Culture procedure 
A 100 ~1 sample of material to be tested for the presence of chlamydiae was 
inoculated on an Hela 229 monolayer formed on a round coverslip in a flat 
bottomed tube. Except when the inoculum was the laboratory strain L-2, the 
monolayer was washed twice with 30 ~g/ml diethylaminoethanol (DEAE) dextran in 
Hank's balanced salt solution before inoculation. After centrifuging the 
inoculated monolayers at 3700 g for one hour we added 1 ml growth medium which 
consisted of Eagle's modified minimal essential medium which contained 5% 
fetal calf serum, 4.5 mg/ml glucose, 25 U/m1 nystatin, 25 ~g/ml vancomycin and 
25 ~g/ml streptomycin (called CMGA). After three days the monolayers were 
stained by Giemsa's method and evaluated with dark field illumination at 250 x 
magnification. The number of inclusions per 30 microscopic fields or per 
coverslip was counted, and counts were made in triplicate. 
Survival of c. trachomatis serovar L-2 in three media at three temperatures 
A 100 ~1 sample of chlamydia suspension in SPG (75 g sucrose, 0.52 g potassium 
phosphate, 1.22 g disodium acid phosphate, and 0.72 g L-glutamine, dissolved 
in 1 1 water) was added to 0. 9 ml of the test medium. The three media used 
were Earle's balanced salt solution, CMGA, and 2SP, and all contained 10% 
fetal calf serum. Portions of the medium containing chlamydiae were incubated 
at 4"C and at room temperature and frozen at -70"C. Samples were obtained at 
intervals and the number of inclusion forming units (ifu) in them was 
measured. 
Processing of patient material 
An aluminium swabstick (ENT swab, Boehringer, Mannheim, FRG) was used to 
obtain a urethral sample from men attending the outpatient clinic for sexual-
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ly transmitted diseases (STD) of the Rotterdam University Hospital. The 
material was suspended in 2SP and divided into three portions; one was stored 
at 4•c, the second at -7o·c, and of the third portion a fraction was inoculat-
ed immediately while another fraction was stored at room temperature. After 24 
and 48 hours the samples stored at 4•c and at room temperature were inoculated 
in triplicate. After one week the samples stored at -7o·c were thawed and 
inoculated. The 2SP medium also contained 25 U/ml nystatin, 20 ~g/ml vancomy-
cin, and 25 ~g/ml streptomycin. 
Table I Comparison of survival of c. trachomatis serovar L-2 after 
suspension in three media at three temperatures for varying times 
Mean No (%) inclusions per 30 microscope 
fields (x 250 magnification) of three 
coverslips produced by lo-3 dilution of 
the suspensions on: 
Storage temperature 
and time CMGA EBS 2SP 
Room temperature 
4 hours 263 (100) 358 (100) 396 (100) 
8 hours 213 (81) 344 (96) 293 (74) 
25 hours 33 (13) 41 (ll) 179 (45) 
50 hours 3 <<1) 3 <<1) 22 (6) 
4·c 
4 hours 396 (100) 446 (100) 571 (100) 
50 hours 10 (3) 15 (3) 30 ()5)* 
80 hours 8 (2) 15 (3) 30 ()5)* 
120 hours 1 (1) 1 (1) 30 ()5)* 
-7o·c 
2 days 223 (100) 205 (100) 264 (100) 
6 days 16 (7) 16 (8) 57 (20)11 
1 week 12 (5) 13 (6) 50 (18)1/ 
2 weeks 26 (12) 22 (ll) 62 (22)1/ 
CMGA = Eagle's modified minimal essential medium; EBS = Earle's 
balanced salt solution; 2SP = 0.2 mol/1 sucrose in 0.02 mol/1 
phosphate buffer. 
*At 50, 80, and 120 hours )100 inclusion were counted in a lo-1 
dilution on 2SP. 
112SP proved to be significantly (p<o.o5) (Student's t test) 
superior to the other media. 
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RESULTS 
Our comparison of survival in different culture media showed that chlamydiae 
survived best in 2SP at all temperatures studied. Table I lists the number of 
inclusions obtained by inoculating a 1o-3 dilution of the suspensions in 
phosphate buffered saline (PBS). Undiluted 2SP suspensions produced 158 and 96 
inclusions after storage for 150 and 174 hours respectively at room tempera-
ture. Clinical conditions were probably best mimicked by diluted suspensions. 
In general these showed substantial reduction of inclusions after storage for 
25 hours at room temperature, 50 hours at 4•c, and six days at -7o·c. 
Table II Number of positive cultures obtained from patient material 
after immediate inoculation compared with results after storage 
No of positive cultures after: 
Storage temperature Immediate Storage 
and time inoculation (%) 
Room temperature 
24 hours 46 39 (85) 
48 hours 44* 38 (86) 
4"C 
24 hours 46 41 (89) 
48 hours 45* 40 (89) 
-70"C 
1 week 44* 39 (89) 
*Some samples were not tested under all storage conditions. 
Table II shows the results of our investigation into the effect of storing 
material from patients on chlamydia! survival. Storing reduced the number of 
positive cultures by 11-15% depending on the storage temperature. Storing 
patient material also unmistakably reduced the number of inclusions per cover-
slip. Table III shows that this reduction depended on storage times and 
temperatures and amounted to 40-70% of the number of inclusions formed after 
inoculation of the material immediately after sampling. Eleven positive speci-
mens became negative under one or several storage conditions and averaged 
seven inclusions per coverslip, while 27 remained positive under all storage 
conditions and averaged 98 inclusions per coverslip. Table IV shows that in a 
group of patient samples which gave negative results after immediate inocula-
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tion, 4% (7 of 178) gave positive results after storage for 48 hours at 4"C, 
and 2% (4 of 162) after 1 week at -70"C. 
Table III Effect on number of inclusions by storing patient 
material at three temperatures for different times 
Percentage of inclusions on immediate 
inoculation after storage for: 
Storage 
temperature 24 hrs 
Room temperature 50 
4"C 60 
-70"C 
48 hrs 
30 
60 
l week 
55 
Significant (Student's t test; p < 0.05) difference between 
number of inclusions after 48 hours at room temperature and 
one week at -70"C, and between 48 hours at 4"C and 48 hours 
at room temperature. 
Table IV Number of cultures of patient material which were negative 
after immediate inoculation and positive after postponed inoculation 
No of negative cultures 
after immediate 
inoculation 
No (%) of positive cultures after: 
178 
162* 
48 hrs at 4"C 
7 (4) 
*No material was stored at -70"C from 16 patients. 
DISCUSSION 
1 week at -70"C 
4 (2) 
The experiments with our laboratory strain L-2 show that 2SP is a better 
storage and transport medium than Earle's balanced salt solution and CMGA. We 
do not know why survival is better in 2SP, but the fact that sucrose is cryo-
protective may play a part (7). 
As might be expected, the sensitivity of the culture diminishes when the 
patient material is not immediately inoculated on the monolayer. The number of 
inclusions decreases noticeably, but the influence of this decrease on the 
culture is of course limited. After all the demonstration of only one inclu-
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sian is enough to give a positive result. A correlation exists, however, 
between the number of inclusion forming units in the initial material and the 
reversion of culture results after storage, with fewer inclusions increasing 
the risk of reversion. Apart from the difficulty of finding a single inclusion 
in a specimen, the degeneration of chlamydiae constitutes a real problem in 
this context. 
Immediate freezing, the procedure routinely followed for patient material, 
produces a loss of 11% inclusions. When the unfrozen material is in transit 
for one or two days this loss increases to 25%. The loss is compensated for 
only partly by positive results in material found to be negative after imme-
diate inoculation. A possible explanation for this finding lies in the intra-
cellular localisation of chlamydiae. Freezing or storage can cause the euka-
ryotic host cells to break open. Brief sonication of the patient material 
immediately before inoculation would therefore seem to be rational. The dis-
integration of toxic material during storage might also play a part (6). 
Facilities for culturing chlamydiae are restricted to a few centres. Proper 
processing of the materials can therefore encounter logistical problems which 
unfavourably affect the sensitivity of the culture method. Ridgway inoculated 
patient material immediately and after transport to a central reference 
laboratory, which entailed loss of 22.6% (8). 
This study stresses the necessity to process patient material as quickly as 
possible. One has to deal with an unacceptable loss in sensitivity by 
transporting material for chlamydia! culture, unless there are laboratory 
facilities to inoculate specimens directly. 
We thank M S den Boer, W Kuiper-Dikland, and E Prens for collecting patient 
material. This study was supported by Pfizer B V, The Netherlands. 
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CHAPTER 4 
EVALUATION Of THE DIRECT flUORESCENT ANTIBODY TEST fOR DIAGNOSIS Of CHLAMYDIAL 
INfECTIONS* 
K.H. Tjiam, R.v.w. van Eijk, B.Y.M. van Heijst, G.J. Tideman, Th. van Joost, 
E. Stolz, M.F. Michel 
The direct fluorescent antibody test and two culture methods were compared for 
accurate diagnosis of chlamydia! infections. Using the same samples, 109 were 
found to be positive in the microtitre method with the direct confirmation 
test without subpassage, whereas 66 were positive in the vial method with 
Giemsa staining and sub passage. The direct test was evaluated for accuracy 
using cervical and male urethral specimens. Specimens for culture were 
obtained prior to sampling for the direct test. For cervical samples the 
sensi ti vi ty of the direct test, with the vial method taken as reference, 
appeared to be 72.2% with a specificity of 93.5%. With the microtitre method 
as standard, these values were 55.9% and 91.3%, respectively for females, and 
for male patients 49% and 95.6%, respectively. For cervical samples, in which 
sampling for the direct test was carried out prior to sampling for culture, 
these values were 46.3% and 93.2% respectively. Both culture method and study 
population influenced the sensitivity of the direct test. According to our 
findings, the direct test cannot replace the culture method for diagnosis of 
chlamydia! infections. 
INTRODUCTION 
Chlamydia trachomatis is an obligate, intracellular microorganism, which has 
been increasingly acknowledged to cause sexually transmitted non-gonococcal 
genital infections. An accurate means of diagnosing chlamydia! infections is 
mandatory in view of the complications possible in infected women. Culture 
testing is considered the most reliable method for detection of Chlamydia, 
although the required transportation of specimens and culturing facilities 
pose problems. Recently it has become possible to detect chlamydia! antigens 
*Eur. J. Clin. Microbial. 1985;4:548-552. 
28. 
in specimens with either an enzyme immunoassay ( 1) or immunofluorescence 
techniques (2, 3). 
The aim of this study was to evaluate the direct fluorescent antibody test 
(DT) by comparing its accuracy with the major culture methods: the vial method 
with Giemsa stain and the microtitre method with immunofluorescence staining 
for detecting inclusions. We also determine the value of simple laboratory 
techniques such as Gram stain and urine sediment for predicting culture 
results, which could potentially be used to screen high-risk populations. 
MATERIALS AND METHODS 
Study Population 
The study population consisted of unselected male and female patients who 
attended the venereal disease outpatient clinic of the University Hospital 
Rotterdam, The Netherlands. The males formed three groups: urethritis patients 
(n= 95) with more than ten leucocytes in the resuspended urine sediment of 
20-40 ml of first-voided urine (250x); patients (n= 35) complaining of dysuria 
and/or discharge but showing no abnormalities in the urine sediment; and 
asymptomatic males (n= 92) with neither complaints nor sediment abnormalities. 
The women (n= 416) were assigned a semiquantitative score of 0-4 based on the 
number of leucocytes in the cervical Gram stain (800x): 0 = no leucocytes, 
1 = 1-5/field, 2 = 6-10/field, 3 = 11-20/field, 4 = )20/field. 
Male and female patients with gonorrhoea were excluded from the study. 
Sampling Procedure 
In the males with discharge, specimens were first obtained for the Gram stain. 
Next, a metal cotton-tipped swab was moistened in transport medium and then 
inserted 4-5 em into the urethra and rotated gently before withdrawal. After 
this specimen was suspended in the vial containing transport medium, the swab 
was inserted again, rolled over a microscopic slide for the direct test, and 
placed in the transport vial. Finally, 20-40 ml of first-voided urine was 
collected for the two-glass test, after material was sampled for gonococcal 
culture. In the females, specimens from both urethra and cervix were obtained 
for Gram stain and gonococcal cultures. The sampling procedure described above 
was used for chlamydial detection. In a second part of our study, only 
material from the cervix was sampled with a dry cotton-tipped swab. The order 
of obtaining specimens was also reversed, specimens for the direct test being 
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taken first. In the latter group chlamydia! cultures were carried out by the 
microtitre method. 
Transport Medium 
The transport medium (2SP) consisted of 1.5 ml of 0.2 M sucrose in 0.02 M 
phosphate buffer, supplemented with 5% foetal calf serum (FCS), 25 f.Lg/ml 
gentamicin and 2.5 f.Lg/ml amphotericin B. Within 6 h of suspending the sample 
in the medium, the tubes were stored at -7o•c. 
Culture Method 
For the vial culture method 200 f.Ll specimen were inoculated in duplicate on a 
Hela 229 monolayer, grown on a 12-mm round glass coverslip in a flat-bottom 
tube. Prior to inoculation the monolayer was rinsed with 30 f.Lg/ml DEAE-dextran 
in Hank's balanced salt solution. After centrifugation of the vials at 3000 g 
for 1 h, the inoculum was replaced by growth medium consisting of Eagle's 
Minimal Essential Medium, modified with 4.5 mM glucose, 5% FCS, 25 f.Lg/ml gen-
tamicin, 25 f.Lg/ml vancomycin, and 2.5 f.Lg/ml amphotericin B. After incubation 
for 72 h at 36•c the monolayer was fixed, stained with Giemsa and screened for 
the presence of inclusions by darkfield illumination (250x). The duplicate 
vial was sonicated for 10 s prior to inoculation on a fresh monolayer for 
subpassage . 
A modification of the method described elsewhere (4) was used in the micro-
titre plates. Specimens were inoculated in two wells (200 f.Ll/well) of a 
96-well microtitre plate (Falcon No. 3070) on a Hela 229 monolayer pretreated 
with DEAE dextran. After centrifugation at 3000 g for 1 h, the inoculum was 
replaced by lOOf.Ll growth medium, and the plate incubated at 36•c in a C02 
incubator for 48 h. Next the monolayer was fixed and subsequently stained with 
fluorescein-conjugated monoclonal antibodies (MicroTrak Culture Confirmation 
Test, Syva Inc. Munster IN). The plates were examined inverted under a Leitz 
fluorescence microscope, using a lens with long focal length (320x). Duplicate 
microtitre plates were used for subpassage. The monolayer was disrupted by a 
freeze-thaw procedure. 
Direct Test 
Patient specimen was rolled over a circular area (8 mm diameter) etched on the 
slide. The smear was dried, fixed for l min in acetone and stored at -20 • C 
until staining. Staining was done with the MicroTrak Direct Specimen Test 
(Syva Inc.). Slides were scored positive if ten or more chlamydia! particles 
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were observed, according to the manufacturer's recommendations. Only slides 
with epithelial cells present were considered. The slides and cultures were 
examined without prior knowledge of the result of the other test. 
Statistical Method 
Fisher's exact test was used to determine the level of significance. 
RESULTS 
When the vial method was tested without subpassage, 50 of 1116 male urethral 
and cervical samples were positive; with subpassage 80 were positive, 
signifying an increase of 60%. Subpassage proved less important for the micro-
titre method. Of 926 male urethral and cervical specimens cultured with the 
microtitre method 110 were positive without subpassage and 123 with, an 
increase of only 11.8%. A comparison of the accuracy of the vial method with 
subpassage (V) and the microtitre method without subpassage (MT) using 
932 male urethral and cervical samples (Table 1) showed more positive cultures 
with MT (109) than with V (66). 
Table l Comparison of the microtitre (MT) and the vial 
method (V) for detection of Chlamydia from the cervix and 
male urethra in 932 specimens. 
No. of test reactions 
v + + 
Specimen origin MT + + 
Male urethra 23 7 27 262 
Cervix 26 10 33 544 
Total 49 17 60 806 
The results of the direct test were then compared with the MT and V methods 
(Table 2). Thirty-four of 301 (11.3%) cervical, and 25 of 296 (8.4%) female 
urethral specimens, and 49 of 252 (19.4%) male urethral specimens were culture 
positive with the MT method. With the V method the respective percentages 
were 7.3, 2.7, and 9.5, and with the direct test they were 11.3, 7.4, and 
13.1, respectively. 
Table 2 Comparison of the results of the microtitre method, direct test and vial 
methods. 
Microtitre method 
Vialmethod 
Direct Test 
Cervix leucocyte score 3-4 
Cervix leucocyte score 0-2 
Cervix total8 
Female urethra 
Males with urethritis 
Males without urethritis 
Male urethra totals 
A 
+ 
+ 
+ 
A 
8 
4 
13 
2 
8 
3 
15 
B 
+ 
+ 
No. of 
B 
3 
2 
5 
3 
4 
l 
6 
Pattern of reaction 
c D E F G H 
+ + 
+ + 
+ + + 
patients with reaction pattern 
c D E F G H 
2 1 2 1 5 66 
1 1 8 5 152 
6 3 10 1 12 251 
7 1 D 2 12 256 
6 3 8 3 63 
3 8 3 109 
9 3 19 6 194 
8 Leucocyte scores and sediment abnormalities were not determined in all patients. 
Table 3 Sensitivity and specificity of the direct test (DT) using either 
the microtitre (MT) or vial method (V) as standards. Values in percent. 
Sensitivity Specificity 
with reference to with reference to 
Patient subgroups MT v MT v 
Cervix leucocyte score 3-4 66.7 71.4 91.8 90.7 
Cervic leucocyte score 0-2 33.3 71.4 95.6 95.8 
Cervic total8 55.9 72.7 94.4 93.5 
Female urethra 36 37.5 95.2 93.4 
Males with urethritis 53 .a 73.3 91.3 88.7 
Males without urethritis 40 75 97.3 95.1 
Male urethra total8 49 75 95.6 93.4 
aleucocyte scores and sediment abnormalities were not determined in all 
patients. 
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The MT method was positive for 14 of 48 ( 29.2%) chlamydia-infected women 
solely on the basis of urethral samples. The sensitivities and specificities 
of DT using either culture method as standard were also analysed by subgroups 
(Table 3). The overall sensitivity of the DT with the MT as standard in 
cervical and male urethral specimens was 55.9% and 49~~ respectively. Higher 
values, 72.7% and 75% respectively, were calculated if V was taken as 
standard. No difference was observed in sensitivities of the DT using either 
standard with female urethral specimens. The sensitivity of DT compared to 
that of MT appeared to be dependent on the subpopulation under consideration: 
In the presence of a high leucocyte score of 3-4 a higher sensitivity (66.7%) 
was found than in the subgroup with low leucocyte scores of 0-2 (33.3%). In 
male patients, higher sensitivites were also detected in those with 
urethritis. The order of obtaining specimens was reversed in a subsequent 
study in which only cervical specimens were taken into account. DT specimens 
were sampled prior to culture; 41 of 188 (21.8%) were chlamydia-positive in 
the MT. The overall sensitivity and specificity were 46.3 and 93.2% respecti-
vely. The sensitivity of the DT was significantly higher in the group with 
leucocyte scores of 3-4 than in the group with scores of 0-2 (76.5% vs 15.8%, 
p < 0.05). Specificities were 92.7% and 93.6% respectively. The prevalences of 
positive cultures were 29.3% in the former group and 19.6% in the latter. 
There was a correlation between leucocyte score and percentage of positive 
cultures in cervical samples. In the groups with leucocyte score of 0, 1, 2, 
3, and 4, the percentages chlamydia-positive women were 7.1, 8, 20.9, 21.6, 
and 29.2, respectively. Thus, a leucocyte score of 2-4 had a predictive value 
for a positive and a negative culture of 18.1% and 92.9%, respectively. In 
95 of 222 (42.8~~) males, a diagnosis of urethritis was established on the 
basis of the urine sediment in the two-glass test. Of these 95 males, 26 
(27.3%) were chlamydia-positive. Sensitivity, specificity, and predictive 
values for a positive and a negative culture result were in this group 63.4%, 
61.9%, 27.4%, and 88.2%, respectively. Neither signs of urethritis nor 
complaints of discharge and/or dysuria were apparent in 11 of the 41 
chlamydia-positive males (26.8%). 
DISCUSSION 
Our results show the superiority of the microtitre method with immunofluor-
escence detection of inclusions over the more traditional vial method with 
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Giemsa staining. The two methods differ from each other in inoculum size per 
monolayer surface, incubation conditions and detection method. As our ~tudy 
was undertaken to compare the accuracy of the two culture methods with that of 
the nonculture method, it was not possible to determine the contribution of 
each parameter to the greater sensitivity of the MT. 
The advantages of fluorescein-conjugated monoclonal antibodies for the detec-
tion of chlamydial inclusions have been described by other investigators (4, 
5). In their studies subpassage appeared necessary in both vial and microtitre 
systems for detection by Giemsa or iodine staining. They also found a 55% 
increase in positive cultures, agreeing with our results. However, we found 
that immunofluorescence without subpassage gave better results than Giemsa 
staining and subpassage (Table 1). 
Yoder et al. (6) also compared the microtitre method with the vial technique, 
using iodine to detect inclusions. The two methods did not clearly differ in 
sensitivity, although the inoculum varied. Moreover, in the microtitre wells, 
only a 100 pl sample was used in contrast to a 200 J.Ll sample in the vials. 
Centrifugal force of llOO g was applied in the MT method as compared with 
2400 g in the V method. However, by increasing the force from 1000 g to 
3000 g, the number of positive specimens rose nearly threefold (7, 8). The 
superiority of the MT method might therefore have been more apparent if Yoder 
et al. (6) had used larger inocula and a greater centrifugal force. This might 
explain out 65% increase in positive cultures with the microtitre method with 
immunofluorescence detection without subpassage (Table 1). 
We were not able to confirm the very good results with the direct test 
described elsewhere (2, 3, 9). Although our twofold sampling technique and 
modified culture method might have negatively influenced the sensitivity of 
the DT, neither the use of an insensitive culture method (V) nor the 
classification of subgroups with a high chlamydial prevalence yielded tne high 
sensitivities of 93-100% described elsewhere, Maximal sensitivity was obtained 
in the female subgroup with a high leucocyte score of 3-4, when specimens for 
DT were sampled prior to culture ( 76.5%). In particular, the results with 
female urethral specimens were disappointing. Unfortunately, such specimens 
have not been evaluated by others. Nevertheless, the female urethra proved to 
be an important sampling site: in 29.2% of all chlamydia-infected women, the 
organism could be isolated only from the urethra. The sensitivity for male 
urethral specimens was also lower than that reported elsewhere, but we took 
specimens for the culture only prior to sampling for the DT. 
Our results illustrate the influence of both culture technique and study 
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population on the sensitivity of the DT. There was also a distinct correlation 
between the sensitivity of the DT and the number of leucocytes at the 
sampling site. Both the percentages of chlamydia-positives and DT sensitivity 
increased at higher leucocyte scores. The correlation between higher 
inflammatory response and presence of more infectious particles was also 
apparent from the study of Brunham et al. (10). Twenty of 40 women (50%) with 
more than ten leucocytes in the cervical Gram stain (lOOOx) were chlamydia-
positive compared to only two of 60 women without this finding. 
Theoretically the low sensi ti vi ty of the direct test might be increased by 
considering less than ten chlamydial particles a positive result. However, 
Uyeda (3) was not able to detect any change in sensitivity when he altered the 
cutoff value from two to 10 particles. 
The occurrence of culture-negative, but DT-positive results might be due to 
J 
artefacts, insensitive culture techniques or non-viable organisms. Which of 
these factors is involved in our study remains to be investigated. 
To evaluate a new test like the DT, an optimal culture method should be used. 
The technique, sampling procedure and study population must also be exactly 
described. Our findings indicate that the direct test cannot replace the 
culture method for diagnosing chlamydial infections. 
The expense of these methods for detecting chlamydia recommend more selective 
screening of women. Since our results indicated a predictive value of 92.9% 
for a negative culture result in women with a score <2, as was the case in 
156 of 401 women studied (38.9%), the screening could be restricted to women 
with a score )2. 
Unfortunately, there does not appear to be a comparable group of male 
patients. Adger et al. (ll) reported that a positive culture gave a predictive 
value of 91% in the case of sediment abnormalities in first-voided urine. We 
were unable to confirm this result, finding a predictive value of only 27.4%. 
The same result was obtained when the study population was restricted to those 
with more than 20 (instead of 10) leucocytes in the sediment of a first-voided 
urine sample. In Rotterdam, however, such patients always receive therapy for 
a chlamydial infection: 2 g tetracycline orally per day for 7 days. More 
important are those chlamydia-positive men without complaints or signs of 
urethritis. They amounted in this study to ll of 41 chlamydia-positive men 
(26.8%), which is in agreement with findings reported previously (12). Since 
such patients are able to transmit the infection if not treated, culture 
screening of these asymptomatic men appears warranted in high-risk popula-
tions. 
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CHAPTER 5 
EVALUATION OF AN ENZYME IMMUNOASSAY FOR THE DIAGNOSIS OF CHLAMYDIAL INFECTIONS 
IN UROGENITAL SPECIMENS* 
K. Hong Tjiam, B. Yvonne M. van Heijst, Anneke van Zuuren, Johan H.T. Wagen-
voort, Thea van Joost, Ernst Stolz, Marc F. Michel 
A total of 194 male urethr<:d and 402 cervical specimens were obtained from 
patients at the venereal disease outpatient clinic of University Hospital, 
Rotterdam, The Netherlands, to evaluate the IDEIA test (Boots Celltech) for 
the detection of chlamydial infections. The prevalences of cul ture-posi ti ve 
males and females were 17.5 and 8.2%, respectively. The respective overall 
sensitivities and specificities found were 67.6 and 93.7% for the males and 
63.6 and 93.8% for the females. The highest sensitivity (83.3%) was found in 
male patients with more than 20 leukocytes per field in the sediment of the 
first-voided urine (magnification, x250) and in women with more than 10 leuko-
cytes per field in a cervical Gram stain (magnification, x800). However, in 
men without urethritis and in women with fewer than 10 leukocytes per field in 
the Gram stain, sensitivities of 44.4 and 40%, respectively, were found. 
Culture-positive, IDEIA-negative results were predominantly observed in 
samples with few inclusions in the culture. 
INTRODUCTION 
The diagnosis of chlamydial infections is based mainly on the culture of the 
organism on He La 229 or McCoy cells, a procedure which takes 2 to 6 days, 
depending on the method used. The culture requires cell culture facilities, 
and the transport and storage of the patient's material may influence the 
I 
reliability of the results con~iderably (6, 9). 
Recently, antigen-detecting techniques have been developed and tested for the 
purpose of overcoming these disadvantages. They are based either on an enzyme 
*J. Clin. Microbial. 1986;23:752-754. 
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immunoassay (2, 3, 11) or on an immunofluorescence technique (4, 8, 10). These 
methods take only a few hours to perform and eliminate the need for viable 
organisms. 
In view of the high prevalence of chlamydia! infections, thorough evaluation 
of these quick diagnostic tests in several centers seems indicated. In this 
study, cervical and male urethral samples were obtained from patients at a 
venereal disease outpatient clinic to evaluate the performance of the IDEIA 
test (Boots Celltech) in the detection of chlamydia! infections. In this test, 
antigen is detected with a genus-specific monoclonal antibody in an amplified 
enzyme immunoassay. 
MATERIALS AND METHODS 
Study population. Visitors to the venereal disease outpatient clinic of the 
University Hospital in Rotterdam, The Netherlands, were screened for, among 
other things, chlamydia! infections. A total of 402 cervical and 194 male 
urethral samples were investigated. Patients suffering from gonorrhoea were 
excluded from the study. In the males, a Gram stain of a sample from the 
urethra was made first. Next, endourethral samplings for the IDEIA, chlamydia! 
culture, and gonococcal culture were carried out consecutively. A diagnosis of 
urethritis was made if more than 10 leukocytes per field were found in the 
sediment of 30 to 40 ml of the first-voided urine (magnification, x250). 
In the women, cervical material was sampled for Gram stain, gonococcal 
culture, IDEIA, and chlamydia! culture, in that order. The number of leuko-
cytes in the Gram stain was semi quantitatively determined, with scores of 
0 to 4 as follows: 0, no leukocytes; 1, 1 to 5 leukocytes; 2, 6 to 10 leuko-
cytes; 3, 11 to 20 leukocytes, and 4, more than 20 leukocytes per field 
(magnification, x800). 
Sampling procedure. A metal cotton-tipped swab was used both for the IDEIA and 
for the culture. The swab for the IDEIA was suspended in 1 ml of transport 
medium (Boots Celltech) after endourethral or endocervical insertion and rota-
tion. The sample, which was contained in a 2.5-ml polypropylene tube, was 
stored at 4"C and processed within 3 days. When this treatment was not possi-
ble, it was stored at -70"C and processed within 1 week. This procedure did 
not influence the test results. 
Patient's material on the swab for culture was suspended in 1.5 ml of 2SP 
(0.2 M sucrose in 0.02 M phosphate buffer with 10% fetal calf serum, 25 ~g of 
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gentamicin per ml, and 25 U of nystatin per ml). The same swab was introduced 
endourethrally or endocervically once again, rotated, and stored within 
6 hours in 25P, at -7o·c. 
Table l Prevalence of chlamydia! infection and discordant 
and concordant IDEIA results among groups of patients 
Type of patient 
Male 
With nongonococcal urethritis 
With nongonococcal urethritis 
Without urethritis 
Female with score of: 
4 
3 
2 
l 
0 
No. of patients with 
microtiter culture/IDEIA 
results: 
+/+ +/- -1+ -/-
C)2o)a 10 2 2 29 
(10-20)a 9 4 5 30 
4 5 3 91 
4 22 
11 3 13 85 
5 6 8 124 
2 2 70 
l l 45 
aNumber of leukocytes in sediment of first-voided urine. 
Culture method. A modified culture method as described by Stamm et al. (7) was 
used. A sample (200 fLl) was inoculated on a Hela 229 monolayer, which was 
grown in a 96-well microtiter cell culture plate (Falcon no. 3070). The 
monolayer had been rinsed with 30 /Lg of DEAE-dextran in Hank's balanced salt 
solution per ml prior to inoculation. Two wells per sample were used. After 
centrifugation for 1 h at 3,000 x g, the sample was replaced by 100 fLl of 
growth medium (minimal essential medium; Eagle's medium modified with 5% fetal 
calf serum, 4.5 mM glucose, 25 /Lg of vancomycin per ml, 25 /Lg of gentamicin 
per ml, and 25 U of nystatin per ml). After 48 h of incubation at 37•c, the 
monolayer was fixed and stained with the MicroTrak Confirmation Test (Syva 
Inc.). The microtiter plates were turned upside down and screened for the 
presence of inclusions with a fluorescence microscope equipped with a Leitz 
long-distance objective (32x). 
IDEIA method. For the IDE IA method, samples were placed in a boiling-water 
bath for 15 min. A cooled specimen (200 fLl) was added to duplicate wells on 
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Table 2 Sensitivity, specificity, and predictive values for positive and negative 
test results of the IDEIA, with the culture method as the golden standard among 
groups of patients 
Results (%) of IDEIAa 
Type of patient n 
Sensitivity Specificity PV(+) PV(-) 
Male 
With nongonococcal urethritis ()2o)b 43 83.3 93.5 83.3 93.5 
With nongonococcal urethritis (10-20)b 48 69-2 85-7 64.3 88.2 
Without urethritis 103 44.2 96.8 57.1 94.8 
Overall result 67.6 93.7 69.7 93.2 
Female with leukocyte score of: 
3-4 138 83.3 89.2 53.6 97.3 
0-2 264 40C 95.8 37.5 96.4 
Overall result 63.6 93-8 47.7 96.6 
a PV(+), Predictive value for positive test result; PV(-), predictive value for 
negative test result. 
b Number of leukocytes in sediment of first-voided urine. 
c p (0.05 with regard to sensitivity in women with a leukocyte score of 3 to 4. 
a 96-well microtiter plate, which was coated with genus-specific monoclonal 
antibodies. These antibodies react both to elementary bodies and to group-
specific lipopolysaccharide antigen. A total of 46 samples could be tested in 
one plate. In every plate, four wells were used for two positive and two 
negative controls. 
After incubation for 2 h at room temperature, 50 ~1 of alkaline phosphatase-
conjugated monoclonal antibody was added to each well. Next, after incubation 
and a washing procedure, this solution was replaced by 100 ~l of NADP. The 
addition of 200 ~1 of amplifier caused the development of a red-coloured 
formazan derivative in the case of a positive result. The A492 was read with a 
Titertek Multiskan spectrophotometer. A value greater than 0.2 optical density 
units above the mean absorbance reading of the negative control was regarded 
as a positive result. 
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Definitions of sensitivity, specificity, and predictive value for positive 
and negative results. Definitions of terms are as follows: sensitivity (%) = 
(number of culture-positive persons with a positive IDEIA test/number of 
culture-positive persons tested) x 100; specificity (%) = (number of culture-
negative persons with a negative IDEIA test/number of culture-negative persons 
tested) x 100; predictive value for positive test result = (number of culture-
positive persons with positive IDEIA test/number of persons with positive 
IDEIA test) x 100; predictive value for negative test result = (number of 
culture-negative persons with negative IDEIA test/number of persons with 
negative IDEIA test) x 100. 
Statistical methods. The Fisher exact test was used to determine statistical 
significance. 
RESULTS 
Of 194 male patients, 34 (17.5%) were culture positive, as were 33 (8.2%) of 
402 women. Urethritis patients were divided into a group with more than 
20 leukocytes in the urine sediment (n = 43) and a group with 10 to 20 leuko-
cytes in the sediment (n = 48). Women were classified by the semiquantitative 
leukocyte score (Table 1). The highest prevalences of culture-positive 
chlamydia! infections were seen in the urethritis patients (27 .5%) and in 
women with leukocyte scores of 3 and 4 (12.5 and 15.4%, respectively). In 
males without urethritis (n = 103) and in women with leukocyte scores of 0, 1, 
and 2 the prevalences were 8.7, 4.3, 2.7, and 7.7%, respectively. 
From the discordant and concordant results, it was possible to calculate the 
sensitivity and specificity of the test for different patient groups. The 
culture results were taken as the "golden standard" (Table 2) . In male pa-
tients, the sensitivity decreased from 83.3% in those with more than 20 leuko-
cytes in the urine sediment to 44.4% in those without urethritis. The overall 
sensitivity and specificity were 67.6 and 93.7%, respectively. 
In women with a leukocyte score of 3 to 4, the sensitivity was 83.3%, compared 
with 40% in those with a leukocyte score of 0 to 2 (p < 0.05). The overall 
sensitivity and specificity were 63.6 and 93.8%, respectively. 
To evaluate the discrepant culture-positive, IDEIA-negative results, the 
number of inclusions was determined in 47 culture-positive samples. Culture 
samples were always inoculated in duplicate wells (see Materials and 
Methods). Culture-positive, IDEIA-negative samples were found to be positive 
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in only one well significantly more often than were culture-positive, IDEIA-
positive samples, which were predominantly positive in both wells (p < 0.05; 
Table 3). 
In previous experiments, a significant relationship was found between a high 
number of inclusions in either of two wells inoculated with the same specimen 
and a concordant culture result in both wells. Positive samples which gave 
more than 20 inclusions in one or both wells appeared to be more often 
positive in both wells (p < 0.01; Table 4). 
DISCUSSION 
Table 3 Relationship between culture-positive, IDEIA-negative 
specimens and the culture result in two wells inoculated with the 
same sample 
No. of specimens with culture/ 
Culture IDEIA results: 
results in 
two wells +I- +!+ 
Concordant 13 37 
Discordant 12 sa 
ap < o.o5 
Table 4 Relationship between culture result in two wells 
inoculated with the same sample and the number of inclusions in 
either of the monolayers 
Culture 
results in 
two wells 
Concordant 
Discordant 
No. of patients with inclusions 
~20 
11 
18 
)20 
Our results show that the sensitivity of the IDEIA is strongly dependent on 
the study population (Table 2). A higher sensitivity was observed in patients 
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with urethritis or with a leukocyte score of 3 to 4 than in those with a 
leukocyte score of 0 to 2 or without urethritis. A relationship was found to 
exist between a high number of leukocytes and a high prevalence of chlamyqial 
infections (Table 1). This observation is in agreement with the findings of 
Brunham et al. (1), who were able to diagnose a chlamydia! infection in 50% of 
women with mucopurulent cervicitis but in only 2 of 40 women without 
cervicitis. Van Ulsen et al. (11) also found an enzyme immunoassay test to 
have a higher sensitivity in men with urethritis than in men without urethri-
tis. Moreover, culture-positive, IDEIA-negative results were predominantly 
observed in samples with few inclusions in the culture (Tables 3 and 4). These 
observations suggest that there is a positive correlation between the strength 
of the inflammatory response and the number of infectious chlamydia! 
organisms. From these findings it may be inferred that the sensitivity of 
antigen-detecting systems is dependent on the antigen level available for 
analysis. 
The culture method used is superior to the more traditional vial method with 
subpassage and Giemsa stain. In our system, two wells per sample were used, 
and the centrifugal force was increased from 1,100 x g (7) to 3,000 x g. 
According to Reeve et al. (5), this increase could mean a 30% augmentation of 
positive culture results. Besides, sampling of culture specimens occurred by 
double swabbing, which might improve the yield. However, we did not carry out 
studies to confirm this issue. The use of a more sensitive culture technique 
as the standard will obviously lead to a lower sensitivity of the test under 
investigation. 
Caul and Paul ( 2) reported a sensitivity and specificity of 95.5 and 99%, 
respectively, with the IDEIA. However, they did not describe in detail the 
study population and the culture method used. The results of another chla-
mydia! antigen-detecting enzyme immunoassay, performed in different labora-
tories, also revealed discrepancies (3, 11). From our study it seems likely 
that discrepancies in test results may be attributable in part to differences 
in study populations and culture techniques. 
Unfortunately, the IDEIA has a low sensitivity in patients lacking inflamma-
tory symptoms, such as men without urethritis and women without cervicitis. 
These patients in particular will not be treated in the absence of adequate 
diagnostic facilities and are therefore able to transmit the infection in-
advertently. 
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CHAPTER 6 
THE PRESENCE OF SEXUAllY COMMUNICABLE MICRO-ORGANISMS IN HUMAN SEMEN SAMPLES, 
TO BE USED FOR ARTIFICIAl INSEMINATION BY DONOR* 
K.H. Tjiam, B.Y.M. van Heijst, A.A. Polak-Vogelzang, Ph.H. Rothbarth, 
Th. van Joost, E. Stolz, M.F. Michel 
Twohundred thirty-seven semen samples from 10 institutions for arti fie ial 
insemination by donor (AI) in Belgium and the Netherlands were tested for the 
presence of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, 
Ureaplasma urealyticum, herpes simplex virus and cytomegalovirus. The 
prevalence of these micro-organisms in the semen samples was 0%, 6.3%, 4.6%, 
35.9%, 0% and 0.4% respectively. Forty percent of all samples were found to be 
infected with one or more of these micro-organisms. As the ejaculates from 
which the samples had been taken had already been or would be used for AID 
purposes, it seems indicated to exclude microbiological contamination with 
sexually communicable micro-organisms prior to insemination. 
INTRODUCTION 
Artificial insemination by donor (AI) is used thousands of times a year in the 
Netherlands and Belgium in cases of male infertility. In general, microbiolo-
gical examination of the semen samples prior to insemination is incomplete, 
especially as use is often made of fresh semen. In view of the epidemic 
incidence of sexually communicable diseases it would seem to be important that 
semen samples intended for AI should be subjected to such tests as are 
necessary to prevent iatrogenic infections in women. For this reason, a study 
was set up in Rotterdam, the Nether lands, to investigate the incidence of 
Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma 
urealyticum, herpes simplex virus and cytomegalovirus in frozen semen samples 
which had been or would be used for AI. 
*Accepted in Genitourinary Medicine 
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MATERIALS AND METHODS 
Semefl samples 
Twohundred thirty-seven semen samples frozen at -196oC, from ten AI institutes 
in the Netherlands and Belgium, were supplied in 0.25 ml or 0.5 ml straws. The 
semen was given voluntarily by the donors, who received a small sum for 
expenses. The samples were all diluted 2:1 or 1:1 with a cryoprotective liquid 
containing glycerol and sometimes also egg yolk or bovine serum albumin. Fifty 
samples contained ampicillin (380 ~g/ml) and 36 contained kanamycin (5 ~g/ml). 
Forty samples came from an institution which used only fresh semen. The semen 
was diluted 1:1 with Eagle's modified Minimal Essential Medium (EMEM) with 15% 
foetal calf serum and frozen to -196°C. 120-200 ~1 of sample were diluted with 
2 ml of EMEM for the culture of N. gonorrhoeae, C. trachomatis, herpes simplex 
virus and cytomegalovirus. 60-200 ~1 of sample were suspended in 2 ml of U-9 
medium (1) for the culture of M. hominis and U. urealyticum. 
Culture methods 
Culture for Neisseria gonorrhoeae (Ng) 
The sample diluted with EMEM was inoculated with a loop on a medium consisting 
of GC mediumbase (Difco), haemoglobin (Difco) and Isovitalex (BBL) and 
incubated for 48 hours. 
Culture for C. trachomatis (Ct). 
200 ~1 of the sample diluted with EMEM were again diluted 1:1 with EMEM. Of 
each dilution, 200 ~1 per well were inoculated in duple on a Hela 229 mono-
layer which had been pre-rinsed with 30 ~g/ml DEAE dextran and grown in a 
96-well microtiter plate (Falcon 3070). After centrifugation for 1 hat 3000 g 
the inoculum was replaced by 100 ~1 of EMEM with 4.5 mM glucose, 5% foetal 
calf serum, 25 U/ml nystatin, 25 ~g/ml gentamicin, 25 ~g/ml vancomycin. After 
incubation for 48 h at 37oC the monolayers were screened for the presence of 
inclusions after colouring with fluorescent monoclonal antibodies (Syva Inc.). 
Culture for herpes simplex virus (HSV) and cytomegalovirus (CMV) 
200 ~1 of the sample diluted with EMEM were put on a leighton tube in which a 
HEL cell monolayer had been grown. Inoculation was carried out in duple. After 
incubation for 1 h at 37oC the inoculum was replaced by 1.5 ml of Dulbecco MEM 
with 2% foetal calf serum. The medium was renewed every week. After 3 weeks 
the cells were transferred to new tubes. The cell culture was maintained for 
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6 weeks. If a cytopathogenic effect was present the monolayer was coloured 
with virus-specific fluorescent monoclonal antibodies (M.A. Bioproducts). 
Culture forM. hominis (Mh) en U. urealyticum (Uu). 
The medium of Chanock (2) was used for Mycoplasma cultures. Yeast extract was 
prepared as described by Hers (3) and inactivated horse serum was applied. U-9 
and A-7 media (l, 4) were used for the Ureaplasma cultures. Ureaplasma was 
detected by the phenol-red colouring in the U-9 medium and the typical colony 
form revealed by microscopic examination of the A-7 plate. Mycoplasma was 
recognized by the colony form on Chanock's medium, and further identified with 
the indirect immunofluorescencetest of unfixed colonies (5). 
RESULTS 
Neither gonococci nor HSV were cultivated from any of the 237 samples. The 
prevalence of C. trachoma tis, M. hominis, U. urealyticum and CMV was 6 .3%, 
4.6%, 35.9% and 0.4% respectively (Table 1). Forty percent of the samples were 
found to be infected with one or more of the micro-organisms studied. Fifteen 
of the 237 samples (6.3%) were infected with two or three micro-organisms. The 
microbiological screening of the semen samples carried out by the institutes 
and the upper limit of leukocytes accepted varied widely. Six institutes did 
not perform any microbiological tests on their samples. None of the institutes 
carried out a culture for HSV or CMV. Though two institutes examined the 
samples for Ureaplasma and Mycoplasma, some of them were nonetheless found to 
be infected with these micro-organisms. Two of 50 ampicillin-containing 
samples were chlamydia-positive. The culture of Mycoplasma and/or Ureaplasma 
were positive in ll out of 25 kanamycin-containing specimens. Two of the 
10 institutes carried out a urine sediment examination of the donor. 
DISCUSSION 
Micro-organisms were found to be present in 40% of the 237 semen samples 
intended for AI. This percentage is probably a minimum value. The quantity of 
sample which could be extracted from the straws varied fairly widely 
(120-200 p.l). Moreover, the samples had to be diluted in order to avoid a 
cytotoxic effect on the cell lines used. On the other hand, however, a 
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Table l Culture results in 237 semen samplesll 
Micro-organism2 No. of positive culture results 
C. trachomatis 15 ( 6 .3) 
M. hominis ll ( 4.6) 
U. urealyticum 85 (35.9) 
Cytomegalovirus 1 ( 0.4) 
None 142 (59 .9) 
1) The origin of one sample is unknown; the 
culture results were negative. 
2) All cultures of N. gonorrhoeae and herpes 
simplex virus were negative. Percentages 
are given in parenthesis. 
decrease in the concentration of semen components which have a growth-
inhibiting effect might enhance the chlamydial cultures (6). The presence of 
kanamycin and ampicillin in a number of specimens tested will inhibit the 
growth of gonococci, Chlamydia, Mycoplasma and Ureaplasma. 
The examinations carried out by the institutes are not sufficient to rule out 
the presence of these micro-organisms in the semen they use. The only way for 
the institutions to ensure that the samples they obtain are free of pathogens 
is for them to carry out the necessary examinations of the donor and the semen 
sample. The presence or absence of micro-organisms does not seem to be related 
to other properties of semen, such as motility, abnormal morphology and leuco-
spermia (7, 8). Nor do physical and simple laboratory examinations of the 
donor provide conclusive evidence, as carriership of micro-organisms causing 
sexually communicable diseases, is frequently asymptomatic. 
In view of the large number of inseminations carried out annually, it is 
notable that little mention is made in the literature of genital infections in 
the recipients caused by AI. Gonococcal and Ureaplasma infections transmitted 
through AI have, however, been described (9, 10). Moreover, gonococci, 
Chlamydia and other bacteria, including beta-haemolytic streptococci, have 
been reported to survive a freezing procedure (11, 12, 13, 14). The incidence 
of these other bacteria was not investigated in this study, nor was the 
incidence of hepatitis B and HTLV-III virus. However, the occurrence of HTLV-
III virus infections through AI has recently been described (15) and sero-
logical examination of the donor for both of these viruses is therefore 
certainly indicated. 
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It is not known whether the contaminated semen samples have caused infections 
in the recipients. It is not clear either whether the presence of the culti-
vated micro-organisms is of pathogenic significance. This will be determined 
by the number and serotype of the micro-organism in question and by the 
condition of the recipient's defense mechanisms. 
However, the importance of C. trachomatis as a pathogenic agent in urethritis, 
cervicitis, salpingitis, neonatal conjunctivitis and pneumonitis has been well 
documented (16). 
M. hominis is associated with salpingitis, pyelonephritis and postpartum 
fever, while U. urealyticum is linked with chorioamnionitis and possibly low 
birth weight (17). One of the causes of the "TORCHES" syndrome in neonates is 
a congenital CMV infection. 
The results of this screening therefore point to the need to examine both the 
donor and the semen prior to insemination in order to avoid contamination with 
pathogenic micro-organisms. This implies that only frozen semen samples should 
be used for AI purposes. 
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CHAPTER 7 
PREVALENCE OF ANTIBODIES TO CHLAMYDIA TRACHOMATIS, NEISSERIA GONORRHOEAE, AND 
MYCOPLASMA HOMINIS IN INFERTILE WOMEN* 
K.H. Tjiam, G.H. Zeilmaker, A.Th. Alberda, B.Y.M. van Heijst, J.C. de Roo, 
A.A. Polak-Vogelzang, Th. van Joost, E. Stolz and M.F. Michel 
SUMMARY 
A total of 57 infertile women who had been referred for in vitro fertilisa-
tion or for diagnostic laparoscopy, were tested for the presence of antibodies 
to Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis. Four 
were excluded from the study. Of the remaining 53, 33 had laparoscopically 
obvious tubal disorders, such as adhesions, distal occlusions and strictures, 
and 20 did not. Antibodies to C. trachomatis were found in 7/33 (21.2%) v 
0/20, antibodies to N. gonorrhoeae in 20/38 (60.6%) v 5/20 (25%), and anti-
bodies to M. hominis in 18/24 (75%) women with tubal disorders v 13/19 (68.4%) 
of those with no disorder. Antibodies to C. trachomatis and N. gonorrhoeae 
were significantly (p ( 0.05) more common in women with tubal disorders. The 
high prevalence of antibodies to N. gonorrhoeae in infertile women without 
tubal disorders suggests that ciliated tubal epithelium is damaged after 
inflammation without this being laparoscopically visible. Our results confirm 
the important role of N. gonorrhoeae and C. trachomatis in the aetiology of 
infertility after tubal inflammation. 
INTRODUCTION 
Salpingitis may lead to tubal infertility, the relative risk of which, after 
one or more episodes of salpingitis, varies between 12.8% and 75% (1, 2). 
Moreover women who have had salpingitis have a sevenfold to tenfold risk of 
ectopic pregnancy. Tubal damage after infection is estimated to be an aetiolo-
*Genitourin. Med. 1985;61:175-8. 
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gical factor in 30% to 40% of infertile women (2). Most cases of salpingitis 
are caused by the ascending spread of infection from the lower genital tract. 
Acute salpingitis has a polymicrobial aetiology. Anaerobic micro-organisms 
such as Peptostreptococcus, Peptococcus, Clostridium and Bacteroides species 
have been isolated, either individually or in combination with N. gonorrhoeae, 
M. hominis, or C. trachomatis (3). The relative importance of these organisms 
as causative agents has not been agreed. In the United States gonococci and 
anaerobes are more commonly associated with salpingitis than in Sweden (4) and 
France (5), where most isolates yield C. trachomatis. These differences in the 
prevalence of causative organisms may be attributed to epidemiological 
factors, the length of time after infection, and the methods used for taking 
specimens for culture. Moore et al. showed antibodies to C. trachomatis in 73% 
of infertile women with distal tubal occlusion, but antibodies could not be 
detected in women with normal tubes (6). Punnonen et al. (7) and Conway et al. 
(8) made similar observations. These studies did not, however, evaluate anti-
bodies to M. hominis or N. gonorrhoeae. 
We undertook the study reported here to assess the relative importance of 
N. gonorrhoeae, M. hominis and C. trachomatis as organisms causing tubal in-
flammation leading to infertility by measuring the prevalence of antibodies 
to these organisms in a group of infertile women. 
PATIENTS AND METHODS 
Study population 
We tested serum from 57 women who had been infertile for at least 18 months 
and had been referred by their doctors to the gynaecological outpatient clinic 
of the University Hospital Rotterdam, the Netherlands for in vitro fertilisa-
tion or diagnostic laparascopy. 
Classification of disorders of the fallopian tubes 
We regarded the presence of peritubal adhesions, strictures, tubal occlusions, 
or a combination of these disorders as a macroscopic feature of tubal disease. 
This was the case in 33 women, two of whom showed only peritubal adhesions. 
The 20 women who did not show such abnormalities were considered to be in-
fertile for unknown reasons. Four women had well documented causes of tubal 
disorders: one had had endometriosis, two had had tuberculous salpingitis, and 
one had had peritonitis after a perforated appendix. These four women were 
Table I Demographic, historical, and serological findings in relation to the condition of fallopian 
tubes as seen at laparoscopy 
Mean (SEM) age (years) 
No (%) with secondary infertility 
Mean (SEM) duration of infertility (years) 
No (%) with history of salpingitis 
No (%) with chlamydia! antibodies 
No (%) with gonococcal antibodies 
No (%) with chlamydia! or gonococcal antibodies, or both 
No (%) with mycoplasmal antibodies 
*p < 0.001; **O.Ol(p(0.05. 
Tubal disorder 
32.0(0 .7) (n=33) 
17/33 (51.5%) 
7 .4(0 .8) (n=31) 
14/20 (70%) 
7/33 (21.2%) 
20/33 (60.6%) 
24/33 (72 .7%) 
18/24 (75%) 
No tubal disorder 
31.4(0 .9) (n=20) 
9/20 (45%) 
5.2(0.7) (n=l8) 
1/16 (6 .3%)* 
0/20 (0%)** 
5/20 (25%)** 
5/20 (25%)* 
13/19 (68 .4%) 
Table II Prevalence of chlamydia!, gonococcal and mycoplasmal antibodies in infertile women related to historical data 
History of: 
Salpingitis 
Secondary infertility 
Ectopic pregnancy 
*0.01( p < 0.05 
No (%) with chlamydia! 
antibodies/No with or 
with no history 
With history No history 
5/14(35. 7) 1/23 (4.3)* 
4/29(13.8) 2/27 (7.4) 
1/9 (11.1) 6/48(12.5) 
No (%) with gonococcal 
antibodies/No with or 
with no history 
With history No history 
9/15(60) 9/23(39 .l) 
12/29(41.4) 14/29(51.9) 
4/9 (44.4) 22/48(45 .8) 
No (%) with chlamydia! or No (%) with mycoplasmal 
gonococcal antibodies, or antibodies/No with or 
both/No with or with no with no history 
history 
With history No history With history No history 
12/15(80) 9/23(39.1)* 9/14(64 .3) 13/12(61.9) 
14/29(48.3) 15/27(55.6) 21/27 (77 .8) 12/24(50) 
4/9 (44.4) 26/48(54 .2) 5/8 (62 .5) 28/44(63 .6) 
V1 
V1 
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excluded from evaluation. 
Investigations of infertility 
We recorded each patient's age and history of pregnancy, salpingitis, pelvic 
surgery, and the use of an intrauterine device (IUD). Infertility investiga-
tions consisted of semen analysis, basal temperature curve, postcoital test, 
hysterosalpingography, and laparoscopy with intrauterine injection of 
methylene blue to assess tubal patency. 
Serology tests 
We tested serum samples for the presence of antibodies to c. trachomatis by 
the microimmunofluorescence technique of Wang et al. (9). Six pooled antigens 
were used: A to C, DE, FG, I, J, and K. A titre of ) 1/8 was consisted to be 
positive. Antibodies against gonococcal pili antigens were shown by an enzyme 
linked immunosorbent assay (ELISA), as described by Oranje et al. (10). An 
extinction of )1.15 was considered to be positive. Anti-human immunoglobulin 
conjugate was used in both tests. 
Antibodies to M. hominis were shown by the indirect immunofluorescence method 
of Rosendal et al. (11). A strain of M. hominis that had been isolated from a 
patient served as antigen. Positive control serum was kindly supplied by 
Dr. K. Lind (Statens Serum Institut, Copenhagen, Denmark). Serum dilutions of 
1/40 and 1/80 were prepared for the test. Anti-human IgG conjugate was used. 
Serum samples, from 25 healthy women blood donors aged 22 to 34 were tested 
for the presence of the above mentioned antibodies. 
Statistical methods 
The x2 method for independent samples was used to assess the level of 
significance. 
RESULTS 
Table I shows that significantly more (o.m< p <0.05) women with macroscopi-
cally visible tubal disorders had antibodies to C. trachomatis and to gono-
coccal pili in their serum than those without such disorders. Positive 
serology test results for chlamydiae were found in seven (13.2%) out of 53 
women. In these seven women the most common serogroup was DE (in five women) 
followed by A-C (in four) and FG (in four), I (in three) and J (in two.). In 
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three out of these seven women only one antigen pool could be found. Anti-
bodies to gonococcal pili antigen were present in 25 (47.2%) out of 53 women. 
Antibodies to M. hominis were present in 31 (72%) out of 43 women, of whom 18 
had tubal disorders and 13 did not. Of the 25 women blood donors, none had 
antibodies to C. trachomatis, one had antibodies to gonococcal pili, and four 
had antibodies to M. hominis. 
Table II shows that antibodies to C. trachomatis were significantly 
(O.Ol<p<0.05) more common in women with a history of salpingitis. Antibodies 
to gonococcal pili were also more common in such women, although not 
significantly so. Antibodies to M. hominis were found more commonly in women 
with secondary infertility than in those with primary infertility. The number 
of women (nine) with a history of ectopic pregnancy was too small to allow 
statistical analysis. As the historical data on the use of IUDs were 
incomplete, these were not evaluated. 
Table III shows that the predictive value for the presence of mascroscopically 
visible tubal disorders in serum containing chlamydia! or gonococcal anti-
bodies, or both, ranged from 64.2% to 94.4%. 
Table III Predictive value of positive serology test results 
for tubal disorders, as seen at laparoscopy 
Serology test results 
Ch1amydial antibodies 
Gonococcal antibodies 
Chlamydial or gonococcal antibodies, or both 
DISCUSSION 
Predictive value 
within 95% 
confidence limits 
59-100 
59.3-93.2 
64.2-94.1 
The prevalence of antibodies to C. trachomatis in our patients was low (13.2%) 
compared with that (about 30%) observed by Moore et al. (6). Epidemiological 
differences in the prevalence of chlamydia! infections in both populations 
might offer an explanation for this discrepancy. Moreover, the mean duration 
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of infertility in women in our study with tubal disorders was 7 years and 
4 months, and in women without such disorders it was 5 years and 2 months. The 
length of time after infection that antibodies to chlamydiae were demonstrable 
in man remains to be assessed. Mgrdh reported the disappearence of IgG and IgM 
antibodies after l year and 5 months despite initial high titres ( 12). The 
long duration of infertility may have affected our results. Moore et al. found 
a mean duration of raised titres of four years, which was considerably. less 
time than we found in our study. 
The high prevalence of antibodies to gonococcal pili both in the total study 
population (47 .2%) and in the women with tubal disorders (60.6%) was un-
expected. Mgrdh detected gonococcal antibodies in less than 18% of 60 women 
with laparoscopically confirmed salpingitis (4). Eschenbach et al., however, 
found positive serology test results in 84% for 38 patients with salpingitis 
and gonococcal cervicitis and in 36% of 35 patients without current gonorrhoea 
(3). 
Our findings suggest a higher prevalence of gonococcal than chlamydia! infec-
tions at the time of salpingitis. In 248 women, who attended the venereal 
diseases outpatient clinic in Utrecht, the Netherlands in 1979-80, 
N. gonorrhoeae was isolated in 34%, C. trachomatis in 15%, and M. hominis in 
63% (13). 
Gonococcal antibodies were found in 25% of infertile women without laparosco-
pically obvious tubal disorders. This figure was considerably higher than that 
for gonococcal antibodies in our blood donors, which may indicate that gross 
examination by laparoscopy does not detect all tubal abnormalities in patients 
with tubal infertility. In such patients, dysfunction of ciliated tubal 
epithelium after inflammation may only be detectable by histopathological 
investigations (14, 15). 
Antibodies to M. hom in is were shown in 72% of our study population. The 
prevalence, however, was similar in women with and without tubal disorders. 
(Table I). The role of M. hominis as a causative organism of salpingitis needs 
to be established. Animal studies suggest that it has a role in the aetiology 
of parametritis, rather than salpingitis (17). 
The difference in prevalence of chlamydia! antibodies in women with and with-
out a history of salpingitis was striking (Table II). Antibodies to gonococcal 
pili were also more common in women with a history of salpingitis than in 
those with no such history, but the difference was not significant. In 
general, salpingitis associated with chlamydiae has a clinically milder course 
than that caused by gonococci or anaerobes, which seldom remains unnoticed .. We_ 
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cannot explain our results, which contradict this fact. 
Our study clearly suggests a role for sexually transmitted organisms in the 
aetiology of infertility after tubal inflammation. Prospective studies of 
women with salpingitis, well documented by laparoscopic and bacteriological 
data, are necessary to gain further insight into the role of several micro-
organisms in the development of tubal infertility. The high predictive value 
of the presence of antibodies to chlamydiae or gonococcal pili, or both, for 
the presence of tubal pathology is worth mentioning. 
Positive serological test results may also be valuable in explaining the 
aetiology of infertility in women when this is not known. Testing for these 
antibodies should therefore form a part of every routine infertility 
investigation. 
We thank Mrs P Landsmeer for her technical help. 
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CHAPTER 8 
IN VITRO ACTIVITY OF TEMOCILLIN (BRL 17421) AGAINST CHLAMYDIA TRACHOMATIS* 
K.H. Tjiam, B.Y.M. van Heijst, Th. van Joost, E. Stolz, M.F. Michel 
Sir, 
The susceptibility of Chlamydia trachoma tis to different antibiotics is not 
tested routinely. The great efficacy of tetracycline in eradicating non-gono-
coccal infections of the urogenital tract has probably obviated to a large 
extent cumbersome in vitro testing of the activity of different antibiotics 
against clinically isolated Chlamydia strains. However, some resistance to 
erythromycin has been detected by Mourad (1). In view of this finding and 
because in recent years new antibiotics have been developed whose anti-
chlamydia! activity had not been investigated, the present study was under-
taken. 
Isolates of Chlamydia trachomatis examined in this study comprised ten strains 
from men suffering from non-gonococcal urethritis who attended the venereal 
disease out-patient clinic of the University Hospital, Rotterdam, the Nether-
lands. The strains were passed eight to nine times on Hela 229 cells in order 
to increase the inoculum size. Antibiotics evaluated were cefuroxime (Glaxo, 
England), cefotaxime (Roussel, France), tetracycline (Nogepha, the Nether-
lands), and temocillin (BRL 17421, Beecham, the Netherlands). The latter is a 
semisynthetic ~-lactam antibiotic which is resistant to ~-lactamase produced 
by Neisseria gonorrhoeae. 
Hela 229 cells were maintained and passed on an antibiotic-free medium 
(henceforth called ''growth medium"), consisting of Eagle's Minimal Essential 
Medium modified with 5% fetal calf serum and 4.5 mM glucose. Experiments were 
carried out in flat bottom-tubes containing the Hela 229 monolayer on a glass 
coverslip. The monolayer was inoculated with 100 ~1 of a chlamydia! 
suspension. A proper dilution in phosphate buffered saline was prepared to 
obtain two to nine inclusions per microscope field (magnification x250). After 
centrifugation of the infected mono1ayers at 3,800 x g 1 h, 1 m1 of growth 
*Eur. J. Clin. Microbial. 1984;3:39-40. 
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medium containing the various antibiotics in the desired concentration was 
added. For each antibiotic dilution, four infected monolayers and one control 
(non-infected) monolayer were incubated at 36oC for 60 h. The control mono-
layer was used to detect any cytopathic effect of the antibiotic. 
After incubation, two of the monolayers were fixed with methanol and stained 
with Giemsa to determine, by dark field illumination, the presence of the 
chlamydia! inclusions. In the remaining chlamydia-inoculated monolayers, the 
growth medium was replaced by 1 ml fresh antibiotic-free medium. The cultures 
were frozen at -70oC, thawed twice, and subsequently put on a new monolayer. 
After centrifugation, the medium was replaced by a fresh antibiotic-free one. 
The next passages were carried out in the same way, with the exception that 
sonication for 15 s was employed to disrupt the monolayer instead of the 
freeze-thaw procedure. At this stage, growth medium containing nystatin 
25 U/ml, vancomycin 25 ~g/ml and gentamicin 20 ~g/ml was used. 
Serial two-fold dilutions of antibiotics in growth medium were then carried 
out. The lowest concentration at which monolayers in duplicate vials were free 
from inclusions was considered to be the MIC. The lowest concentration at 
which no inclusion could be seen after three passages was considered to be the 
MBC. In the case of three strains, six passages were carried out. 
Both cefuroxime and cefotaxime showed MIC values )32 ~g/ml, i.e. at the 
highest concentration used. As could be expected from previous investigations 
(2, 3, 4), the cephalosporins tested lacked activity against Chlamydia 
trachomatis. In our out-patient clinic both drugs are commonly given as single 
"one-shot" therapy against gonorrhoea. Hence, this regimen does not eradicate 
a concomittant chlamydia! infection. 
The results of sensitivity testing of temocillin and tetracycline are shown in 
Table 1. Micro-organisms are considered to be susceptible to temocillin if MBC 
values are <16 ~g/ml. According to our in vitro results, temocillin might be 
an effective agent against Chlamydia trachomatis. However, strains 6, 9 and 10 
were isolated from men who developed post-gonococcal urethritis after treat-
ment with lg temocillin i.m. for gonococcal urethritis. Furthermore, strain 6 
showed an MBC value of ). 80 ~g/ml after 6 passages. This illustrates the 
importance of repeated passages in determining an MBC. 
MBC values for tetracycline are approximately the same as those reported else-
where (1, 3); the average blood level of the drug during therapy is supposed 
to be 2-3 ~g/ml. This finding suggests that tetracycline is effective against 
chlamydia! infections. However, the in vitro studies presented here are based 
on a single growth cycle of the organism, while chlamydia! infections require 
Table 1 In vitro activity of temocillin and tetracycline 
against ten Chlamydia trachomatis strains. MIC and MBC 
values are expressed inflg/ml. 
MBC values after six passages are given in parentheses. The 
serial dilutions employed for tetracycline were 0.025 - 0.05 
- o .125 - o .250 - o .sao flg/ml. 
Strain no. Temocillin Tetracycline 
MIC MBC MIC MBC 
1-3 5 5 0.05 0.125 
4-5 10 10 0.05 o.l25 
6 10 10 (~80) 0.125 0.125 (0.125) 
7 10 10 (10) 0.05 0.125 (0.25) 
8 5 5 (5) 0.125 0.125 (0.25) 
9 10 20 0.05 0.125 
10 10 10 (0.125 0.125 
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long-term treatment. Hence no absolute significance may be attributed to MIC 
and MBC values in predicting the clinical efficacy of a drug. 
In view of the high prevalence of chlamydia! infections and the frequent 
choice of tetracycline for the treatment of these infections, conducting 
surveys regularly to determine the susceptibility of clinical isolates seem 
appropriate. 
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IN VITRO ACTIVITY OF THE TWO NEW 4-QUINOLONES OF A56619 AND A56620 AGAINST 
NEISSERIA GONORRHOEAE, CHLAMYDIA TRACHOMA TIS, MYCOPLASMA HOMINIS, UREAPLASMA 
UREALYTICUM AND GARDNERELLA VAGINALIS* 
K.H. Tjiam, J.H.T. Wagenvoort, B. van Klingeren, P. Piot, E. Stolz, 
M.F. Michel 
The in vitro activity of tetracycline, ciprofloxacin and two recently 
developed 1-aryl-fluoroquinolones, A56619 and A56620, was tested against 65 
beta-lactamase-negative and 35 beta-lactamase-positive Neisseria gonorrhoeae 
strains, 12 Chlamydia trachomatis, 50 Mycoplasma hominis, 28 Ureaplasma 
urealyticum and 50 Gardnerella vaginalis. In the case of Chlamydia trachomatis 
and Mycoplasma hominis both the MIC and the MBC were determined. The MIC90 of 
ciprofloxacin for Neisseria gonorrhoeae was 0.008 p,g/ml and of A56619 and 
A56620 ~ 0. 03 p,g/ml. No difference was observed between the activity against 
beta-lactamase-negative and beta-lactamase-positive strains. The MIC90 of 
ciprofloxacin and A56620 for Chlamydia trachomatis, Mycoplasma hominis and 
Ureaplasma urealyticum were identical, the values being 2 p,g/ml, 1 p,g/ml and 
4 p,g/ml respectively. The MIC90 of A56619 for Chlamydia trachoma tis and 
Ureaplasma urealyticum was 0.5 p,g/ml and 1 p,g/ml respectively. The MBC90 of 
the three quinolones for Chlamydia trachomatis and Mycoplasma hominis were 
~ 2 p,g/ml. The activity of the quinolones against Gardnerella vaginalis was 
rather low, the MIC90 being ~4 p,g/ml. It is concluded that A56619 and A56620 
might be useful for single-dose therapy of gonococcal infections. 
INTRODUCTION 
Ciprofloxacin, a recently developed 4-quinolone, has been reported to have a 
very high activity against Neisseria gonorrhoeae and a moderate activity 
against Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum 
(1, 2, 3). Since the quinolones might be of value in the chemotherapy of 
sexually transmitted diseases, the in vitro activity of ciprofloxacin, two new 
1-aryl-fluorquinolones, A56619 and A56620, and tetracycline was tested against 
*Eur. J. Clin. Microbial. 1986;5:498-501. 
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clinical isolates of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma 
hominis, Ureaplasma urealyticum and Gardnerella vaginalis. In the case of 
Chlamydia trachomatis and Mycoplasma hominis both MIC and MBC were determined. 
MATERIALS AND METHODS 
Antibiotics. Ciprofloxacin was obtained from Bayer, FRG, A56619 and A56620 
from Abbott, USA, and tetracycline.HCl from Nogepha, The Netherlands. 
Organisms. The 35 beta-lactamase-positive and 65 beta-lactamase-negative 
Neisseria gonorrhoeae strains, 12 Chlamydia trachomatis, 50 Mycoplasma hominis 
and 28 Ureaplasma urealyticum strains used had recently been isolated from 
specimens obtained from patients attending the venereological outpatient 
department of the University Hospital, Rotterdam, The Netherlands. Fifty 
clinical isolates of Gardnerella vaginalis were obtained from the Institute of 
Tropical Medicine, Antwerp, Belgium. 
MIC and MBC Determinations. 
Neisseria gonorrhoeae. The activity of penicillin G (Gist-Brocades, The 
Netherlands) and cefuroxime (Glaxo, UK) against this organism was also tested. 
Twofold dilutions of antibiotics in water were added to a medium consisting of 
GC medium base (Difco, USA), hemoglobin (Difco, USA) and Isovitalex (BBL, 
USA) . An antibiotic-free control medium was included in each series. The 
organisms to be tested were cultured overnight. Colonies were freshly suspend-
ed in trypticase soy broth (BBL) until an optical density of 0.1 was reached, 
resulting in an inoculum of 106 CFU/ml. These suspensions were inoculated with 
a Steers multipoint replica tor onto the plate series, resulting in spot 
inocula of 104 CFU. All strains were tested for beta-lactamase production by 
the chromogenic cephalosporin test (Nitrocephin, BBL, USA). After incubation 
for 18-20 h in a C02 incubator ( 5%) at 37 "C the MIC was determined by 
observing the lowest concentration of antibiotics in which bacterial growth 
was completely or almost completely inhibited, as judged by the naked eye. A 
haze of growth or a single colony was disregarded. 
Chlamydia trachomatis. Clinical isolates were passed on a Hela 229 monolayer 
seven to nine times in order to increase the inoculum. Hundred p.,l of a test 
strain, containing two to nine inclusions per field (magnification x 320), was 
grown in a 96-well microtiter tissue culture plate (Falcon 3070, Becton 
Dickinson, USA). After centrifugation at 3000 x g for 1 h the inoculum was 
replaced by 100 p.,l of growth medium consisting of Eagle's modified Minimal 
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Essential Medium (Flow, UK) with 10% fetal calf serum and 4.5 mM glucose. 
Twofold dilutions of antibi0tics were prepared in growth medium. After 48 h 
of incubation the monolayers were fixed and subsequently stained with 
fluorescing monoclonal antibodies (Syva, USA). The plate was turned upside 
down and the monolayers were screened for the presence of inclusions with a 
Leitz fluorescence microscope equipped with a long distance objective (32x). 
One row of wells contained growth medium with the maximal concentration of 
each antibiotic but no chlamydiae in order to detect a cytotoxic effect. No 
antibiotic was found to be cytotoxic in the maximal concentration tested. 
Another row of wells contained Chlamydia without antibiotics. Every dilution 
was tested in duplicate. The lowest concentration of antibiotics in which no 
inclusions could be observed was defined as the MIC. A duplicate plate was 
used for the subpassage. The monolayer was disrupted by a freeze-thaw 
procedure. After the second subpassage growth medium was applied with 25 ~g/ml 
gentamicin, 25 ~g/ml vancomycin and 25 U/ml nystatin. Six subpassages were 
carried out to determine the MBC. The MBC was defined as the lowest concentra-
tion of antibiotics in which no inclusions could be observed after the sixth 
sub passage. 
Mycoplasma hominis. The MIC determinations were carried out in 12 x 8 well 
microtiter plates. The growth medium consisted of PPLO broth (Difco, USA) as 
described by Chanock (4), containing 0.05% thallium acetate and 0.2% arginine 
HCl. Twofold dilutions of antibiotics were prepared in growth medium. One well 
contained 200 ~1 of growth medium and 50 ~1 of Mycoplasma hominis suspension, 
resulting in an inoculum size of 3 x 104 to 1 x 105 CFU/ml. After inoculation 
the trays were carefully shaken for 30 min in a Titertek mixer and subsequent-
ly incubated for three days in a C02 incubator (5%) at 35•c. For the MBC 
determination 1 ~1 from each well was inoculated on PPLO agar of the same 
composition as described above but without thallium acetate. MICs were read 
after adding one to three drops of 0.0025% phenol red solution to each well. 
The lowest concentration in which no red-purple colour was developed was 
defined as the MIC. The MBC was defined as the lowest concentration in which 
no surviving organism could be detected, i.e. the lowest concentration causing 
at least 99% reduction of the inoculum in three days. 
Ureaplasma urealyticum. Clinical isolates of Ureaplasma urealyticum were 
cultured on medium 1 consisting of 23.25 g trypic soy broth (Oxoid, UK) 20 ml 
of 1% MnS04.4H20, 110 ml yeast extract as described by Hers (5), 200 ml in-
activated horse serum, 5 ml of 20% urea, 2.5 ml of 4% L-cysteine, 16 g agar 
and 700 ml distilled water. Isolates were transferred to medium 2 consisting 
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of 22.5 g tryptic soy broth, 12.5 ml of 0.2% phenol red, 30 ml yeast extract, 
200 ml inactivated horse serum, 50 ml of 20% of urea and 750 ml distilled 
water. The isolates were kept alive by daily transfer in medium 2. As inocula 
for the MIC determinations, undiluted 18 h cultures in medium 2 were used. 
Twofold dilutions of the antibiotics were prepared in medium 1 and poured 
into petri dishes. Multipoint inoculation was carried out using a Steers 
replicator. Growth was visible on microscopic examination as tiny black 
colonies after 48 h of incubation under anaerobic conditions (95% N2 + 5% C02) 
at 35"C. MICs were also determined on medium 2 with 8.5 g of agar. Growth was 
indicated by a colour change from orange to purple after 30 h of incubation at 
35"C. The MICs determined by the two methods were virtually identical. The 
maximal difference were at most one dilution step. 
Gardnerella vaginal is. The methods used were similar to those for Neisseria 
gonorrhoeae. Twofold dilutions of antibiotics were prepared in a medium 
consisting of Mueller-Hinton agar No. 2 (BBL, USA) with 5% fetal calf serum. 
The plates were incubated at 35"C in a C02 incubator (10%). 
RESULTS 
No difference was observed between beta-lactamase-positive and beta-lactamase-
negative Neisseria gonorrhoeae strains as regards susceptibility to the three 
quinolones tested. Ciprofloxacin displayed the highest activity, with a MIC90 
of 0.008 flg/ml. The two new quinolones, A56619 and A56620, showed similar 
activity, with MIC90 values ~0.03 flg/ml. For beta-lactamase-negative gono-
cocci the MIC50 and MIC90 of penicillin G was 0.08 /Lg/ml and 1.28 /Lg/ml 
respectively. For 2 of 35 beta-lactamase-positive strains and 10 out of 
65 beta-lactamase-negative strains the MIC of tetracycline was 1- 4 flg/ml 
(Table 1). Chlamydia trachomatis appeared to be less susceptible to the quina-
lanes than gonococci, MIC90 values being ~ 1 flg/ml. 
The lowest MIC90 value of the three quinolones tested, 0.5 flg/ml, was found in 
the case of A56619. The MBC90 values of the three quinolones were identical 
(2 /Lg/ml, Table 2). For almost all Mycoplasma hominis strains the MIC and MBC 
values were ~ lfLg/ml and ~ 2 /Lg/ml respectively. The MIC and MBC of cipro-
floxacin for one strain was 2 /Lg/ml. For two strains the MBC of A56620 was 
) 2 fLg/ml, and for two others ciprofloxacin had the same value (Table 2). For 
9 of 49 strains the MBC of tetracycline was ) 2 flg/ml. The MIC of tetracycline 
for two strains and the MBC for another strain was not determined. 
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The MIC50 and MIC90 values of all the agents tested except A56619 were two to 
four times higher for Ureaplasma urealyticum than for Mycoplasma hominis. 
The MIC of tetracycline was not evaluated for two Ureaplasma urealyticum 
strains. 
In general, Gardnerella vaginalis demonstrated lower susceptibility than the 
other micro-organisms to the four agents tested. The MIC90 values of tetra-
cycline, ciprofloxacin, A56619 and A56620 were 
respectively (Table 1). 
DISCUSSION 
~ 32, 4, 8 and 4 p,g/ml 
Our study confirms a previous report in which a high activity of ciprofloxacin 
against both beta-lactamase-positive and beta-lactamase-negative gonococci was 
found (2). In that study an MIC90 of 0.002 p,g/ml was reported, which is lower 
than our value of 0.008 p,g/ml. The activity of penicillin G against the 
strains tested was similar. These findings suggest that ciprofloxacin could be 
of benefit in the therapy of gonococcal infections (6, 7, 8). This was recent-
ly confirmed in a study in 57 men who were cured of gonorrhoea after a single 
oral dose of 250 mg ciprofloxacin (9). In the present study the new 1-aryl-
fluoroquinolones, A56619 and A56620, were also found to display high activity 
against Neisseria gonorrhoeae in vitro. Although human pharmacokinetic data on 
these quinolones have not yet been published, preliminary reports suggest that 
susceptible micro-organisms should include those for which MIC values are 
~ 4 p,g/ml for A56619 and ~ 2 p,g/ml for A56620 (10). In such cases effective 
therapy of gonococcal infections might be expected. 
The activity of ciprofloxacin against Chlamydia trachomatis, Mycoplasma 
hominis and Ureaplasma urealyticum was evaluated in previous studies and MIC 
values of ~ 2 p,g/ml, ~ 0.5 p,g/ml, and 2 p,g/ml respectively were reported (1, 
3). Our study showed similar results. A56619 was found to be more active 
against Ureaplasma urealyticum and Chlamydia trachomatis than the other quina-
lanes. 
Chlamydia trachomatis was susceptible to tetracycline, mean serum levels after 
current therapeutical dosages being 2-3 p,g/ml. However, a relatively high MBC 
(2 p,g/ml) was noted for one isolate. This may have been a slow-growing strain 
which was inhibited incompletely during the short incubation period (48 h) in 
a medium containing tetracycline, although the possibility of cross contamina-
tion cannot definitely be ruled out. For 9 of 49 Mycoplasma hominis strains 
Table 1 MIC values of several antibiotics against Neisseria 
gonorrhoeae, Ureaplasma urealyticum and Gardnerella vaginalis (range of 
MIC values and MIC values required to inhibit up to 50% and 90% of the 
strains respectively). 
MIC ( p.,g/ml) 
Organism Agent Range MIC50 MIC90 
(n) 
Beta-lactamase- tetracycline 0.5 
-4 1 2 
positive cefuroxime ~0-015-1 0.12 0.5 
Neisseria ciprofloxacin o.oo2-o.o15 0.004 o.oo8 
gonorrhoeae A56619 o.oo4-o.o6 o.oo8 0.015 
(35) A56620 0.004-0.015 0.004 0.015 
Beta-lactamase- tetracycline 0.12 -4 0.5 2 
negative cefuroxime ~ 0.01 -1 0.03 0.25 
Neisseria penicillin G o.o1 -2-56 o.oe 1.28 
gonorrhoeae ciprofloxacin o.oo2-o.o15 0.004 o .oo8 
(65) A56619 0.004-0.06 0.015 0.03 
A56620 ~ 0 .001-0.03 o.oo8 0.015 
Ureaplasma tetracycline 0.25- ~ 16 1 2 
ureal}:ticum ciprofloxacin 1 -4 2 4 
(28) A56619 0.5 -1 1 1 
A56620 1 
-8 4 4 
Gardnerella tetracycline 0.25-~ 32 8 ~32 
vagina lis ciprofloxacin 1 - 4 4 4 
(12) A56619 1 - 8 8 8 
A56620 1 - 8 4 4 
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the MBC of ) 2 p.,g/ml. Tetracycline resistance of Mycoplasma hominis has been 
reported previously. A tetracycline MIC ~ 16 p.,g/ml was observed in 27 (34%) 
of 79 isolates (11). 
The clinical efficacy of the quinolones in therapy of genital infections 
caused by Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma 
urealyticum has still to be determined. A single oral dose of 250 mg of cipro-
floxacin has been shown to be insufficient in therapy of Chlamydia trachomatis 
infections, however, single dose therapy has never proved effective in 
eliminating this organism (9). Serum levels ~ 2 p.,g/ml after well-tolerated 
oral ciprofloxacin dosages have been reported, but less is known about the 
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Table 2 MIC and MBC values of four antibiotics against Chlamydia trachomatis and 
Mycoplasma hominis. (range of MBC or MIC values required to inhibit up to 50% and 
90% of the strains respectively). 
MIC l.p-g/ml) MBC (f.Lg/ml) 
Organism Agent range MIC50 MIC90 range MBC50 MIC90 
(n) 
c. trachomatis tetracycline 0.03 -0.25 0.06 0.25 0.03 
- 2 0.125 0-25 
(12) ciprofloxacin 0.125-2 0.25 1 0-25 - 4 1 2 
A56619 o.o6 -0.5 0.25 0.5 0.125- 2 0.5 2 
A56620 0.125-2 o.5 1 0-125- 2 0.5 2 
M. hominis tetracycline 0.25-1 0.5 1 0.5 -)4 1 )4 
(50) ciprof1oxacin 0.5 -1 1 1 1 -)2 2 2 
A56619 0.25-1 0.5 1 0.5 - 1 1 1 
A56620 0.5 -1 1 1 1 - )2 2 2 
tissue distribution of the drug in the urogenital tract (6, 7). Moreover, the 
interaction of the bacteria in the genital tract remains to be elucidated. 
After tetracycline therapy Mycoplasma hominis but not Ureaplasma urealyticum 
appeared to be eradicated, despite similarly low MICs of tetracycline (12). 
The low activity of the quinolones against Gardnerella vaginalis does not 
necessarily mean poor activity in treatment of bacterial vaginosis, as this 
condition is mainly the result of anaerobic overgrowth (13). Metronidazole, 
which is moderately active against Gardnerella vaginalis in vitro, is very 
useful in treating cases of vaginosis. 
In summary, our study shows that A56619 and A56620 have high in vitro activity 
against gonococci. A beneficial therapeutic effect might thus be expected 
after a single oral dose in the case of gonococcal infections. As the in vitro 
activity of these agents against Chlamydia trachomatis, Mycoplasma hominis and 
Ureaplasma urealyticum is lower, higher dosages and prolonged therapy might be 
required in infections with these organisms. 
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CHAPTER 9 
GENERAl DISCUSSION 
The study of Chlamydia survival during transportation of patient material has 
shown an unacceptable decrease in yield of positive samples. If material is 
frozen for subsequent analysis a day after transportation at room temperature, 
the loss increases to 25%. Immediate processing of patient material is there-
fore of crucial importance for the ultimate sensitivity of culture results; in 
actual practice, however, this is rarely possible. 
In view of this antigen-detecting methods seems an asset. Live Chlamydia are 
no longer required and consequently the transportation problem is avoided. 
Unfortunately, the rapid tests so far evaluated have been insufficiently 
sensitive. As might be expected, their sensitivity depends on the culture 
technique used as "golden standard". The microtitre technique without sub-
passage was considerably more sensitive than the traditional vial technique 
with subpassage. For an effective comparison of the test results from various 
research centres the use of the most sensitive culture technique, e.g. the 
microtitre method described, is a prerequisite. Nevertheless the use of these 
antigen-detecting methods may be of some value when logistics for handling 
patient material are poor and the culture technique used is only moderate. The 
result, moreover, is available within a few hours, and this compares 
favourably with the 48 hours required for the microtitre culture method. 
However, the sensitivity of the tests is remarkably low in asymptomatic cases, 
but precisely in these cases rapid, adequate diagnosis is needed to prevent 
dissemination of the infection. Research in the asymptomatic population should 
be part of the evaluation of these tests. The antigen-detecting techniques 
would be useful in centres where a good culture technique is available if they 
might be used as screening tests for chlamydia! infections like the Gram stain 
is used in gonorrhoea. 
The percentage of patients without signs of urethritis among chlamydia-
positive men amounted to 27%. Moreover, the percentage chlamydia! carriers 
among men without signs of urethritis appeared to be 12%. All these men 
belonged to so-called at risk groups. The by no means negligible presence of 
Chlamydia in semen samples to be used in AI (6%) was an unexpected finding. 
The institutes recruit donors mostly from low-risk groups, and the donors in 
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question had had no complaints suggestive of a urogenital infection before 
donating semen. Since the chlamydia! culture from semen is of limited 
sensitivity, the 6% detected probably is a minimum value. The findings show 
that Chlamydia is capable of surviving a freezing procedure as used at AI 
institutes. In addition to Chlamydia, other micro-organisms associated with 
sexually transmitted diseases were found: M. hominis, U. urealyticum and 
cytomegalovirus. Although it is not known whether the presence of these micro-
organisms did produce clinical symptoms in the recipient, it is justifiable to 
recommend that semen to be used in AI be tested more thoroughly for the 
presence of pathogens (3, 4). 
After screening asymptomatic persons for the presence of,Chlamydia, women with 
postinflammatory tubal infertility were studied. This condition can be 
regarded as the most serious complication of an ascending chlamydia! infec-
tion. On the basis of the serology gonococci play a more prominen~ role in the 
aetiology of tubal pathology than Chlamydia. Antichlamydial antibodies were 
much more frequently found in women with tubal infertility studied elsewhere 
(1, 2, 5). Epid~miological differences in Chlamydia prevalence between the 
Netherlands and the USA might be of importance in this respect. A remarkably 
large percentage (30%) of women were unaware of having salpingitis in spite 
their tubal damage. Kosseim (2) reported an even larger percentage (60%). This 
is consistent with Westrom's personal communication that only 15% of his 
patients with salpingitis showed the "classical" symptoms. A practical point 
that can be deduced from the infertility studies is the high predictive value 
of a positive gonococcal and/or chlamydia! serology for the presence of tubal 
lesions. 
Determinations of the MIC and MBC of tetracycline for C. trachomatis strains 
did not point to the existence of resistance to this widely used antibiotic. 
However, regular sensi ti vi ty determinations seems advisable, partly also in 
view of the frequent use of tetracycline in and outside outpatient clinics for 
venereal diseases. The newer 4-fluoroquinolones with a high tissue penetration 
might in future be important as monotherapy for mixed gonococcal-chlamydial 
infections. 
Studies done so far show that methods to detect Chlamydia are far from 
optimal. The sensitive but time-consuming culture technique remains dependent 
on an adequate supply of live Chlamydia in patient material; on the other 
hand, the very rapid antigen-detecting techniques score poorly in the category 
most in need of good diagnostics: asymptomatic patients. 
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As culture methods are expensive, one may raise doubts about the necessity of 
screening every visitor of a venereal diseases outpatient clinic for 
chlamydia! infections. The possibility of treating persons on clinical or 
epidemiological grounds only should also be considered, whereas screening may 
be restricted to asymptomatics (7). Cost-benefit studies are not in favour of 
screening every visitor (6). 
Among Chlamydia carriers a large proportion of the patients is without signs 
of infection. Likewise, screening studies in both high- and low-risk groups 
reveal considerable percentages of chlamydia! infections among men without 
signs of urethritis. Although Chlamydia does not give the impression of being 
aggressive the organism has proved capable of playing a role in the patho-
genesis of postinflammatory tubal infertility. 
Tetracycline remains the antibiotic of choice in the treatment of chlamydia! 
infections; resistance against this agent has not so far been demonstrated in 
vitro. 
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SUMMARY 
Cultures of patient material on continuous cell lines are regarded as the most 
sensitive aid in the diagnosis of chlamydia! infections. Sampling technique, 
transport of material from ward to laboratory and the culture technique as 
such largely determine the ultimate quality. Chapter 3 shows that transfer of 
patient material under suboptimal conditions may cause a 25% loss of positive 
scores. Chapters 4 and 5 describe an improved culture technique on microtitre 
plates which is more sensitive than the traditional technique using vials and 
Giemsa stain. Two antigen-detecting methods for Chlamydia are evaluated in 
these two chapters. Live material is no longer required, and the problem of 
transporting patient material to the laboratory is thus avoided. These 
diagnostic tests, based either on the immunofluorescence technique or on the 
enzyme immunoassay, score very poorly in asymptomatic patients. Precisely for 
this category, however, there is an urgent need for a reliable, rapid 
diagnostic test to prevent epidemiological spreading of the infection. 
The precentage of men without signs of urethritis among Chlamydia carriers 
amounts to 27%. The proportion of chlamydia! infections among men without 
signs of urethritis appears to be 12%. These high percentages are also shown 
in a study described in chapter 6, in which Chlamydia were found in 6% of the 
semen samples to be used in AI. Unlike the population discussed in chapters 
4 and 5, the donors were recruited from low-risk groups. Despite the not very 
aggressive features of Chlamydia indicated by such findings, this organism is 
associated with such serious conditions in women as salpingitis and subsequent 
tubal infertility. The role of Chlamydia in the pathogenesis of postinflamma-
tory tubal infertility is supported by serological findings obtained in in-
fertile women (chapter 7). 
Chapter 8 presents and discusses MIC and MBC values of tetracycline and other 
agents for 22 chlamydia! isolates. These findings show that no in vitro 
resistance to this antibiotic is demonstrable at this time. 
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SAMENVATTING 
De kweek van patientenmateriaal op continue cellijnen wordt beschouwd als de 
meest gevoelige diagnostiek voor Chlamydia-infekies. Afnametechniek, het 
transport van materiaal van kliniek naar laboratorium en de kweektechniek zelf 
bepalen in hoge mate de uiteindelijke kwaliteit. Uit hoofdstuk 3 wordt duide-
lijk, dat het transport van patientenmateriaal onder suboptimale condities een 
verlies van 25% aan positieve score kan teweegbrengen. In hoofdstuk 4 en 5 
staat een verbeterde kweektechniek beschreven op microtiterplaatjes, die veel 
hager scoort dan de traditionele methode met vials en kleuring volgens Giemsa. 
In die hoofdstukken worden twee antigeendetekterende methoden voor Chlamydia 
ge~valueerd. Levend materiaal is niet !anger nodig, zodat het transportpro-
bleem van patientenmonsters naar het laboratorium wordt omzeild. Deze diag-
nostica, gebaseerd op of de immunofluorescentiemethode of de enzyme immuno-
assay scoren zeer slecht bij asymptomatici. Juist bij hen bestaat behoefte aan 
een betrouwbaar diagnosticum om epidemiologische verspreiding van de infektie 
tegen te gaan. 
Zowel het percentage mannen zonder urethritis onder chlamydiadragers als het 
percentage chlamydia-infekties onder mannen zonder urethritis is haag: 27%, 
resp. 12%. Dit blijkt oak uit een onderzoek, beschreven in hoofdstuk 6, 
waarbij in 6% yan de voor KID bestemde spermamonsters Chlamydia werd 
aangetroffen. De donoren behoorden, in tegenstelling tot de onderzochte 
poputatie van hoofdstuk 4 en 5, juist niet tot de risicogroepen. Ondanks 
het weinig agressieve beeld, dat zulke bevindingen van Chlamydia oproept, 
wordt dit organisme oak geassocieerd met ernstige aandoeningen bij de vrouw 
als salpingitis en de daaropvolgende kans op tuba ire infertili teit. De rol 
van Chlamydia bij het ontstaan van postinflammatoire infertiliteit wordt ge-
steund door de resultaten van het serologisch onderzoek van infertiele vrouwen 
(hoofdstuk 7). 
In hoofdstuk 8 worden voor 22 chlamydia-isolaten MIC and MBC waarden van o.a. 
tetracycline bepaald. Hieruit blijkt, voorlopig, nag geen in-vitro resistentie 
voor dit antibioticum aantoonbaar. 
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onderkend, dat in een opleidingssituatie promovendi vaak te weinig tijd wordt 
gegund om naast de -noodzakelijke- klinische taken onderzoek te verrichten. Als 
opleider heeft hij me duidelijk gemaakt, dat een groat associatief vermogen voor 
de uitoefening van de dermatologie belangrijker is dan het memoreren van de vele 
academische syndromen, waaraan ons vakgebied zo rijk is. 
Prof. dr. Marc F. Michel ben ik vee! verschuldigd om zijn niet aflatende zorg 
voor de kwaliteit en voortgang van het werk. De reguliere werkbesprekingen heb-
ben op mij stimulerend en inspirerend gewerkt. 
Dr. Irma Bakker heeft zich, als hoofd van het laboratorium waar ik te gast was, 
vele inspanningen getroost de logistieke voorwaarden te scheppen, die no dig 
waren om mijn taak te kunnen uitvoeren. Doch vooral haar positieve en enthou-
siaste attitude jegens het onderzoek, de waardevolle bijdrage aan de discussies 
en de vele informele gesprekken, laat in de middag, zijn voor mij een grate 
persoonlijke steun geweest! 
Ook de overige ( oud- )medewerkers van de afdeling Klinische Microbiologie en 
Antimicrobiele Therapie wil ik dank zeggen voor de plezierige samenwerking: met 
name Yvonne van Heijst, Annet Roosendaal-de Roo, Anneke van Zuuren-van der 
Horst en Ton de Beer, die als direkt betrokkenen bij het onderzoek zich 
conscientieus en met vee! inzet van hun taak hebben gekweten. 
Van de afdeling Dermatovenereologie zijn de arts-assistenten en assistentes van 
de VD-polikliniek onmisbaar geweest voor het zorgvuldig verzamelen en admini-
streren van patientenmateriaal. Mijn collegae op de polikliniek zijn steeds be-
reid geweest mij de tijd te gunnen voor onderzoeksaktiviteiten. 
Johan van der Stek dank ik voor de vele die's, die hij voor mijn voordrachten 
over Chlamydia heeft vervaardigd. 
De goede samenwerking met dr. Ans Polak-Vogelzang en dr. Ron van Eijk van 
het Rijksinstituut voor Volksgezondheid en Milieuhygiene heb ik als zeer 
positief ervaren. Altijd waren ze bereid onderzoeksideeen een concrete 
vorm te geven. 
Een aparte pleats verdient Prof. dr. Gerard Zeilmaker, a an wiens ini tiatieven 
het te danken is, dat Chlamydia een ruimere bekendheid heeft gekregen dan bin-
nen laboratorium en onder vakbroeders. 
82. 
Pfizer B.V. Nederland dank ik voor de materiele ondersteuning van het onderzoek 
en haar voorlichtingsaktiviteiten. 
En, last but not least, mijn erkentelijkheid voor Ada Beukelman, wier secreta-
riele hulp voor de uiteindelijke vormgeving van dit proefschrift onmisbaar is 
geweest. 
83. 
CURRICULUM VITAE 
De schrijver van dit proefschrift werd in 1948 geboren te Djakarta, Indonesie. 
Na het doorlopen van de HBS-B opleiding te Bussum werd in 1965 begonnen met de 
studie chemische technologie aan de Technische Hogeschool te Delft. In 1972 
werd deze afgesloten met het ingenieursexamen in de richting biochemie 
(Prof. drs. W. Berends). Aan de Medische Faculteit te Rotterdam werd aanslui-
tend de studie in de geneeskunde gevolgd, waar in 1978 het artsexamen werd 
afgelegd. Gedurende de periode 1972-1979 was hij werkzaam als leraar schei- en 
natuurkunde aan HAVO en VWO, vervolgens aan de HBO-B opleiding biochemische 
richting van het Van Leeuwenhoek Instituut te Delft. De opleiding tot dermato-
venereoloog werd in 1979 gestart in het Academisch Ziekenhuis te Rotterdam 
(Prof. dr. E. Stolz, Prof. dr. Th. van Joost). Binnen een samenwerkingsver-
band tussen de afdelingen Dermatovenereologie en Klinische Microbiologie en 
Antimicrobiele Therapie (Prof. dr. M.F. Michel) van de Erasmus Universiteit 
Rotterdam is het chlamydia-onderzoek ter hand genomen, hetgeen heeft geresul-
teerd in het onderhavige proefschrift. Sinds 1 april 1986 is hij werkzaam als 
dermatovenereoloog in het Reinier de Graaf Gasthuis te Delft. 



